FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederick Appelbaum

Research Profile

Procedures

Disorders

Concepts & Ideas

Chemicals & Drugs

Cyclophosphamide

Phenomena

Recurrence

Co-author Network

Publications

TOP 3
S A Buckley; Frederick R Appelbaum; R B Walter
Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.
Elizabeth Trice Loggers; Moreen Shannon-Dudley; Helene Starks; Frederick R Appelbaum; Anthony L Back; F Marc Stewart
Implementing a Death with Dignity program at a comprehensive cancer center.
Roland B Walter; Frederick R Appelbaum; Alan K Burnett; Anna Evans; Robert K Hills; Hagop M Kantarjian; Bob Löwenberg; Gert J Ossenkoppele; Megan Othus; Sherry R Pierce; Farhad Ravandi; Kees G M van Montfort; Elihu H Estey
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederick Appelbaum (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: S A Buckley; Frederick R Appelbaum; R B Walter
Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia.
Bone marrow transplantation 2013;48(5):630-41.
2013: Elizabeth Trice Loggers; Moreen Shannon-Dudley; Helene Starks; Frederick R Appelbaum; Anthony L Back; F Marc Stewart
Implementing a Death with Dignity program at a comprehensive cancer center.
The New England journal of medicine 2013;368(15):1417-24.
2013: Roland B Walter; Frederick R Appelbaum; Alan K Burnett; Anna Evans; Robert K Hills; Hagop M Kantarjian; Bob Löwenberg; Gert J Ossenkoppele; Megan Othus; Sherry R Pierce; Farhad Ravandi; Kees G M van Montfort; Elihu H Estey
Significance of FAB subclassification of "acute myeloid leukemia, NOS" in the 2008 WHO classification: analysis of 5848 newly diagnosed patients.
Blood 2013;121(13):2424-31.
2013: F Ostronoff; M Othus; Stephen H Petersdorf; Jerald P Radich; Derek L Stirewalt; Cheryl L Willman; Frederick R Appelbaum; D E Geraghty; J E Godwin; Phoenix Anh-Dung Ho; M Kutny; Soheil Meshinchi
Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with acute myeloid leukemia: a SWOG report.
Leukemia 2013;27(1):238-41.
2012: Frederick R Appelbaum
Improved outcomes with allogeneic hematopoietic cell transplantation.
Best practice & research. Clinical haematology 2012;25(4):465-71.
2012: Frederick R Appelbaum
Retrospective. E. Donnall Thomas (1920-2012).
Science (New York, N.Y.) 2012;338(6111):1163.
2012: Jerald P Radich; Wendy Stock; Martin Tallman; A Robert Turner; Martha Wadleigh; Peter Emanuel; Suzanne Kamel-Reid; Kenneth J Kopecky; Richard A Larson; Jeff Lipton; Greg Malnassy; Elisabeth Paietta; Frederick R Appelbaum; Michael Deininger; Brian J Druker
A randomized trial of dasatinib 100 mg versus imatinib 400 mg in newly diagnosed chronic-phase chronic myeloid leukemia.
Blood 2012;120(19):3898-905.
2012: Aaron T Gerds; Frederick R Appelbaum
To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision.
Clinical advances in hematology & oncology : H&O 2012;10(10):655-62.
2012: Peter H Wiernik; Frederick R Appelbaum; Peter A Cassileth; Gordon Dewald; Holly Gundacker; Haesook T Kim; Elisabeth Paietta; Marilyn L Slovak; Zhuoxin Sun; Martin S Tallman
Prognostic implications of additional chromosome abnormalities among patients with de novo acute promyelocytic leukemia with t(15;17).
Medical oncology (Northwood, London, England) 2012;29(3):2095-101.
2012: H Joachim Deeg; Min Fang; Frederick R Appelbaum; Boglarka Gyurkocza; David Myerson; John M Pagel; Uwe Platzbecker; Jerald P Radich; Aravind Ramakrishnan; Brenda M Sandmaier; Bart L Scott; Howard M Shulman; Mohamed L Sorror; Derek L Stirewalt; Rainer Storb; Wendy A Wilson; Ted Gooley
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
Blood 2012;120(7):1398-408.
2012: Johnnie J Orozco; Frederick R Appelbaum
Unfavorable, complex, and monosomal karyotypes: the most challenging forms of acute myeloid leukemia.
Oncology (Williston Park, N.Y.) 2012;26(8):706-12.
2012: Aaron T Gerds; Ted A Gooley; Frederick R Appelbaum; H Joachim Deeg; Elihu H Estey; Bart L Scott
Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(8):1211-8.
2012: Philippe Armand; Corey Cutler; H Joachim Deeg; Christopher J Gibson; Vincent T Ho; John Koreth; Stephanie J Lee; Jerome Ritz; Robert J Soiffer; Mohamed L Sorror; Barry E Storer; Edwin P Alyea; Joseph H Antin; Frederick R Appelbaum; Haesook T Kim
A disease risk index for patients undergoing allogeneic stem cell transplantation.
Blood 2012;120(4):905-13.
2012: Frederick R Appelbaum
Haematological cancer: The rule of three in AML induction--is cladribine the answer?
Nature reviews. Clinical oncology 2012;9(7):376-7.
2012: Lauri Burroughs; Paul A Carpenter; H Joachim Deeg; Kris Doney; Mary E D Flowers; Paul J Martin; Jean E Sanders; Barry E Storer; Ann Woolfrey; Frederick R Appelbaum; Rainer Storb
Success of allogeneic marrow transplantation for children with severe aplastic anaemia.
British journal of haematology 2012;158(1):120-8.
2012: Roland B Walter; Elihu H Estey; Frederick R Appelbaum; Irwin D Bernstein
Acute myeloid leukemia stem cells and CD33-targeted immunotherapy.
Blood 2012;119(26):6198-208.
2012: Roland B Walter; Frederick R Appelbaum; Bruno C Medeiros; Bayard L Powell; Charles Alan Schiffer; Elihu H Estey
Phase II trial of vorinostat and gemtuzumab ozogamicin as induction and post-remission therapy in older adults with previously untreated acute myeloid leukemia.
Haematologica 2012;97(5):739-42.
2012: Min Fang; Boglarka Gyurkocza; Brenda M Sandmaier; Barry Storer; Brent Wood; Frederick R Appelbaum
Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
Cancer 2012;118(9):2411-9.
2012: Marco Mielcarek; Robert S Negrin; Rainer Storb; Barry Storer; Thomas R Chauncey; Mary E Flowers; Stephen J Forman; Yoshihiro Inamoto; Paul J Martin; Frederick R Appelbaum; William I Bensinger
Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.
Blood 2012;119(11):2675-8.
2012: Bart L Scott; Mohamed L Sorror; Rainer Storb; Frederick R Appelbaum; Veronika Buxhofer-Ausch; Thomas R Chauncey; Theodore A Gooley; Jonathan Grim; Michael L Linenberger; David Myerson; Jerald P Radich; Andrew R Rezvani; Brenda M Sandmaier; H Joachim Deeg
The Dynamic International Prognostic Scoring System for myelofibrosis predicts outcomes after hematopoietic cell transplantation.
Blood 2012;119(11):2657-64.
2012: Frederick R Appelbaum; Andrea Bacigalupo; Robert Soiffer
Anti-T cell antibodies as part of the preparative regimen in hematopoietic cell transplantation--a debate.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(1 Suppl):S111-5.
2011: Frederick R Appelbaum
The role of hematopoietic cell transplantation as therapy for myelodysplasia.
Best practice & research. Clinical haematology 2011;24(4):541-7.
2011: Roland B Walter; Frederick R Appelbaum; Gautam Borthakur; Jorge E Cortes; Hagop A Kantarjian; Megan Othus; Sherry A Pierce; Farhad Ravandi; Elihu H Estey
Prediction of early death after induction therapy for newly diagnosed acute myeloid leukemia with pretreatment risk scores: a novel paradigm for treatment assignment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(33):4417-23.
2011: Phoenix Anh-Dung Ho; Craig A Hurwitz; Kenneth J Kopecky; Julia Kuhn; Todd A Alonzo; Jeanne E Anderson; Frederick R Appelbaum; Irwin D Bernstein; Janet L Franklin; Alan S Gamis; Robert B Gerbing; John E Godwin; Betsy A Hirsch; Kristen L Miller; Vivian G Oehler; Stephen H Petersdorf; Jerald P Radich; Susana C Raimondi; Gregory H Reaman; Rhonda E Ries; Derek L Stirewalt; Cheryl L Willman; Rong Zeng; Soheil Meshinchi
Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Blood 2011;118(17):4561-6.
2011: Frederick R Appelbaum
Preparative regimens and ageism.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(10):1419-20.
2011: Yoshihiro Inamoto; Paul J Martin; Stephen H Petersdorf; Jean E Sanders; Brenda M Sandmaier; Rainer F Storb; Edus H Warren; Frederick R Appelbaum; Alexander Fefer; Theodore A Gooley; Mary E D Flowers
A phase I/II study of chemotherapy followed by donor lymphocyte infusion plus interleukin-2 for relapsed acute leukemia after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(9):1308-15.
2011: Min Fang; Megan Othus; Brenda M Sandmaier; Barry Storer; Lisa Zhang; Elihu Estey; Frederick R Appelbaum
Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation.
Blood 2011;118(6):1490-4.
2011: Kristine Doney; Mary E D Flowers; Theodore A Gooley; Rainer Storb; H Joachim Deeg; Frederick R Appelbaum
Allogeneic hematopoietic cell transplantation with full-intensity conditioning for adult acute lymphoblastic leukemia: results from a single center, 1998-2006.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(8):1187-95.
2011: John M Pagel; Steven I Park; Jaideep Shenoi; D Scott Wilbur; Frederick R Appelbaum; Amanda Axtman; Tom Bäck; Darrell R Fisher; Shani Frayo; Ajay K Gopal; Damian J Green; Donald K Hamlin; Aimee L Kenoyer; Yukang Lin; Nural Orgun; Johnnie Orozco; Oliver W Press
Anti-CD45 pretargeted radioimmunotherapy using bismuth-213: high rates of complete remission and long-term survival in a mouse myeloid leukemia xenograft model.
Blood 2011;118(3):703-11.
2011: Mikkael A Sekeres; Cheryl L Willman; Deborah Mulford; Tom Norwood; Stephen H Petersdorf; Anjali Advani; Frederick R Appelbaum; Holly Gundacker; Jeffrey Lancet; Jane Liesveld; Alan F List
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.
Blood 2011;118(3):523-8.
2011: Yoshihiro Inamoto; Hans-Peter Kiem; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Mary E D Flowers; Terry Furlong; Marco Mielcarek; Richard A Nash; Rainer F Storb; Barry E Storer; Robert P Witherspoon; Paul J Martin
A retrospective comparison of tacrolimus versus cyclosporine with methotrexate for immunosuppression after allogeneic hematopoietic cell transplantation with mobilized blood cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(7):1088-92.
2011: H Joachim Deeg; Frederick R Appelbaum
Indications for and current results with allogeneic hematopoietic cell transplantation in patients with myelofibrosis.
Blood 2011;117(26):7185.
2011: Roland B Walter; Stephanie J Lee; Kelda M Gardner; Xiaoyu Chai; Kathleen Shannon Dorcy; Frederick R Appelbaum; Elihu H Estey
Outpatient management following intensive induction chemotherapy for myelodysplastic syndromes and acute myeloid leukemia: a pilot study.
Haematologica 2011;96(6):914-7.
2011: Hesham Eissa; Theodore A Gooley; Mohamed L Sorror; Franchesca Nguyen; Bart L Scott; Kristine C Doney; Keith R Loeb; Paul J Martin; John M Pagel; Jerald P Radich; Brenda M Sandmaier; E Houston Warren; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia: relapse-free survival is determined by karyotype and comorbidities.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(6):908-15.
2011: Frederick R Appelbaum
What pediatrics can teach us.
Oncology (Williston Park, N.Y.) 2011;25(4):335, 338, 341.
2011: Bin Xie; Megan Othus; Bruno C Medeiros; Min Fang; Frederick R Appelbaum; Elihu H Estey
Influence of residual normal metaphases in acute myeloid leukemia patients with monosomal karyotype.
Haematologica 2011;96(4):631-2.
2011: Roland B Walter; Theodore A Gooley; Brent L Wood; Filippo Milano; Min Fang; Mohamed L Sorror; Elihu H Estey; Alexander I Salter; Emily Lansverk; Jason W Chien; Ajay K Gopal; Frederick R Appelbaum; John M Pagel
Impact of pretransplantation minimal residual disease, as detected by multiparametric flow cytometry, on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(9):1190-7.
2011: Mary E D Flowers; Yoshihiro Inamoto; Paul A Carpenter; Stephanie J Lee; Hans-Peter Kiem; Effie W Petersdorf; Shalini E Pereira; Richard A Nash; Marco Mielcarek; Matthew L Fero; Edus H Warren; Jean E Sanders; Rainer F Storb; Frederick R Appelbaum; Barry E Storer; Paul J Martin
Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria.
Blood 2011;117(11):3214-9.
2011: Corey Cutler; Aaron S Kesselheim; Steven Gabardi; Borje S Andersson; Paul Carpenter; Hanna J Khoury; Mark Litzow; Scott D Rowley; Scott Lanum; Helen Leather; Ya-Chen Tina Shih; Robert Peter Gale; John R Wingard; Frederick R Appelbaum; Claudio Anasetti
Generic immunosuppressants in hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):285-90.
2011: Eneida R Nemecek; Katherine A Guthrie; Mohamed L Sorror; Brent L Wood; Kristine C Doney; Ralf A Hilger; Bart L Scott; Tibor J Kovacsovics; Richard T Maziarz; Ann E Woolfrey; Antonio Bedalov; Jean E Sanders; John M Pagel; Eileen J Sickle; Robert P Witherspoon; Mary E D Flowers; Frederick R Appelbaum; H Joachim Deeg
Conditioning with treosulfan and fludarabine followed by allogeneic hematopoietic cell transplantation for high-risk hematologic malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(3):341-50.
2011: Frederick R Appelbaum
Unrelated hematopoietic stem cell donors as research subjects.
Bone marrow transplantation 2011;46(1):14.
2010: Frederick R Appelbaum
Dose intensity of preparative regimens for acute myeloid leukemia - one-size-fits-all or tailor-made?
Best practice & research. Clinical haematology 2010;23(4):509-17.
2010: Anjali Advani; Holly Gundacker; Olga Sala-Torra; Jerald P Radich; Raymond Lai; Marilyn L Slovak; Jeffrey E Lancet; Steve E Coutre; Robert K Stuart; Martha P Mims; Patrick J Stiff; Frederick R Appelbaum
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
British journal of haematology 2010;151(5):430-4.
2010: Frederick R Appelbaum
Chemotherapy: Lo and behold, a role for lomustine in acute myeloid leukemia?
Nature reviews. Clinical oncology 2010;7(11):619-21.
2010: Roland B Walter; Frederick R Appelbaum; Martin S Tallman; Noel S Weiss; Richard A Larson; Elihu H Estey
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm.
Blood 2010;116(14):2420-8.
2010: Marcello Rotta; Barry E Storer; Rainer Storb; Paul J Martin; Mary E D Flowers; Miwa S Vernon; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Impact of recipient statin treatment on graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(10):1463-6.
2010: Boglarka Gyurkocza; Rainer Storb; Barry E Storer; Thomas R Chauncey; Thoralf Lange; Judith A Shizuru; Amelia A Langston; Michael Allen Pulsipher; Christopher N Bredeson; Richard T Maziarz; Benedetto Bruno; Finn B Petersen; Michael B Maris; Edward Agura; Andrew Yeager; Wolfgang A Bethge; Firoozeh Sahebi; Frederick R Appelbaum; David G Maloney; Brenda M Sandmaier
Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(17):2859-67.
2010: Edus H Warren; Nobuharu Fujii; Yoshiki Akatsuka; Colette N Chaney; Jeffrey K Mito; Keith R Loeb; Theodore A Gooley; Michele L Brown; Kevin K W Koo; Kellie V Rosinski; Seishi Ogawa; Aiko Matsubara; Frederick R Appelbaum; Stanley R Riddell
Therapy of relapsed leukemia after allogeneic hematopoietic cell transplantation with T cells specific for minor histocompatibility antigens.
Blood 2010;115(19):3869-78.
2010: Phoenix Anh-Dung Ho; Todd A Alonzo; Kenneth J Kopecky; K L Miller; J Kuhn; R Zeng; Robert B Gerbing; Susana C Raimondi; B A Hirsch; Vivian G Oehler; C A Hurwitz; J L Franklin; A S Gamis; Stephen H Petersdorf; Jeanne E Anderson; G H Reaman; Laurence H Baker; Cheryl L Willman; Irwin D Bernstein; Jerald P Radich; Frederick R Appelbaum; Derek L Stirewalt; Soheil Meshinchi
Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Leukemia 2010;24(5):909-13.
2010: Roland B Walter; Hagop M Kantarjian; Xuelin Huang; Sherry A Pierce; Zhuoxin Sun; Holly M Gundacker; Farhad Ravandi; Stefan H Faderl; Martin S Tallman; Frederick R Appelbaum; Elihu H Estey
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(10):1766-71.
2010: Jean E Sanders; Paul A Hoffmeister; Barry E Storer; Frederick R Appelbaum; Rainer Storb; Karen L Syrjala
The quality of life of adult survivors of childhood hematopoietic cell transplant.
Bone marrow transplantation 2010;45(4):746-54.
2010: Paul J Martin; George W Counts; Frederick R Appelbaum; Stephanie J Lee; Jean E Sanders; H Joachim Deeg; Mary E D Flowers; Karen L Syrjala; John A Hansen; Rainer F Storb; Barry E Storer
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(6):1011-6.
2010: Marcello Rotta; Barry E Storer; Rainer F Storb; Paul J Martin; Shelly Heimfeld; Amanda Peffer; David G Maloney; H Joachim Deeg; Brenda M Sandmaier; Frederick R Appelbaum; Marco Mielcarek
Donor statin treatment protects against severe acute graft-versus-host disease after related allogeneic hematopoietic cell transplantation.
Blood 2010;115(6):1288-95.
2010: Thomas R Chauncey; Holly Gundacker; Mazyar Shadman; Alan F List; Shaker R Dakhil; Harry P Erba; Marilyn L Slovak; I-Ming Chen; Cheryl L Willman; Kenneth J Kopecky; Frederick R Appelbaum
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia.
British journal of haematology 2010;148(1):48-58.
2009: John M Pagel; Theodore A Gooley; Joseph G Rajendran; Darrell R Fisher; Wendy A Wilson; Brenda M Sandmaier; Dana C Matthews; H Joachim Deeg; Ajay K Gopal; Paul J Martin; Rainer F Storb; Oliver W Press; Frederick R Appelbaum
Allogeneic hematopoietic cell transplantation after conditioning with 131I-anti-CD45 antibody plus fludarabine and low-dose total body irradiation for elderly patients with advanced acute myeloid leukemia or high-risk myelodysplastic syndrome.
Blood 2009;114(27):5444-53.
2009: Frederick R Appelbaum
Optimising the conditioning regimen for acute myeloid leukaemia.
Best practice & research. Clinical haematology 2009;22(4):543-50.
2009: Terry Furlong; Paul Martin; Mary E D Flowers; F Carnevale-Schianca; R Yatscoff; Thomas R Chauncey; Frederick R Appelbaum; H Joachim Deeg; Kristine C Doney; Robert P Witherspoon; Barry Storer; Keith M Sullivan; Rainer Storb; Richard A Nash
Therapy with mycophenolate mofetil for refractory acute and chronic GVHD.
Bone marrow transplantation 2009;44(11):739-48.
2009: Colleen Delaney; Jonathan A Gutman; Frederick R Appelbaum
Cord blood transplantation for haematological malignancies: conditioning regimens, double cord transplant and infectious complications.
British journal of haematology 2009;147(2):207-16.
2009: Jonathan A Gutman; Wendy Leisenring; Frederick R Appelbaum; Ann Woolfrey; Colleen Delaney
Low relapse without excessive transplant-related mortality following myeloablative cord blood transplantation for acute leukemia in complete remission: a matched cohort analysis.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1122-9.
2009: Soheil Meshinchi; Frederick R Appelbaum
Structural and functional alterations of FLT3 in acute myeloid leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(13):4263-9.
2009: John Koreth; Richard Schlenk; Kenneth J Kopecky; Sumihisa Honda; Jorge Sierra; Benjamin Djulbegovic; Martha Wadleigh; Daniel J DeAngelo; Richard M Stone; Hisashi Sakamaki; Frederick R Appelbaum; Hartmut Döhner; Joseph H Antin; Robert J Soiffer; Corey Cutler
Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.
JAMA : the journal of the American Medical Association 2009;301(22):2349-61.
2009: Fabrizio Carnevale-Schianca; Wendy Leisenring; Paul J Martin; Terry Furlong; Gary Schoch; Claudio Anasetti; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Hans-Peter Kiem; Rainer Storb; George B McDonald; Richard A Nash
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
2009: Marcello Rotta; Barry E Storer; Firoozeh Sahebi; Judith A Shizuru; Benedetto Bruno; Thoralf Lange; Edward D Agura; Peter A McSweeney; Michael Allen Pulsipher; Parameswaran Hari; Richard T Maziarz; Thomas R Chauncey; Frederick R Appelbaum; Mohamed L Sorror; William I Bensinger; Brenda M Sandmaier; Rainer F Storb; David G Maloney
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.
Blood 2009;113(14):3383-91.
2009: Marco Mielcarek; Barry E Storer; Michael Boeckh; Paul A Carpenter; George B McDonald; H Joachim Deeg; Richard A Nash; Mary E D Flowers; Kristine C Doney; Stephanie Lee; Kieren Marr; Terry Furlong; Rainer Storb; Frederick R Appelbaum; Paul J Martin
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2009: Pamela S Becker; Kenneth J Kopecky; Adrianne N Wilks; Sylvia Chien; John M Harlan; Cheryl L Willman; Stephen H Petersdorf; Derek L Stirewalt; Thalia Papayannopoulou; Frederick R Appelbaum
Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.
Blood 2009;113(4):866-74.
2009: Jean E Sanders; Paul A Hoffmeister; Ann Woolfrey; Paul A Carpenter; Barry E Storer; Rainer F Storb; Frederick R Appelbaum
Thyroid function following hematopoietic cell transplantation in children: 30 years' experience.
Blood 2009;113(2):306-8.
2009: John M Pagel; Dana C Matthews; Aimee Kenoyer; Donald K Hamlin; D Scott Wilbur; Darrell R Fisher; Ajay K Gopal; Yukang Lin; Laura Saganic; Frederick R Appelbaum; Oliver W Press
Pretargeted radioimmunotherapy using anti-CD45 monoclonal antibodies to deliver radiation to murine hematolymphoid tissues and human myeloid leukemia.
Cancer research 2009;69(1):185-92.
2008: Frederick R Appelbaum
What is the impact of hematopoietic cell transplantation (HCT) for older adults with acute myeloid leukemia (AML)?
Best practice & research. Clinical haematology 2008;21(4):667-75.
2008: Margaret R O'Donnell; Frederick R Appelbaum; Steven E Coutre; Lloyd E Damon; Harry P Erba; James Foran; Jeffrey Lancet; Lori J Maness; Guido Marcucci; Peter Maslak; Michael Millenson; Joseph O Moore; Farhad Ravandi; Friedrich Schuening; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman; Eunice S Wang; Frank L White
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):962-93.
2008: Ann Woolfrey; Uma Malhotra; Robert D Harrington; John McNevin; Thomas J Manley; Stanley R Riddell; Robert W Coombs; Frederick R Appelbaum; Larry Corey; Rainer Storb
Generation of HIV-1-specific CD8+ cell responses following allogeneic hematopoietic cell transplantation.
Blood 2008;112(8):3484-7.
2008: Bart L Scott; J Y Park; H Joachim Deeg; Kieren Marr; Michael Boeckh; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb; Barry E Storer
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Frederick R Appelbaum
Hematopoietic cell transplantation for non-Hodgkin's lymphoma: yesterday, today, and tomorrow.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2927-9.
2008: Terry Furlong; Hans-Peter Kiem; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Kristine C Doney; Mary E D Flowers; Marco Mielcarek; Richard A Nash; Rainer Storb; Paul J Martin
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
2008: Roland B Walter; Kelli M Boyle; Frederick R Appelbaum; Irwin D Bernstein; John M Pagel
Simultaneously targeting CD45 significantly increases cytotoxicity of the anti-CD33 immunoconjugate, gemtuzumab ozogamicin, against acute myeloid leukemia (AML) cells and improves survival of mice bearing human AML xenografts.
Blood 2008;111(9):4813-6.
2008: Frederick R Appelbaum
Incorporating hematopoietic cell transplantation (HCT) into the management of adults aged under 60 years with acute myeloid leukemia (AML).
Best practice & research. Clinical haematology 2008;21(1):85-92.
2007: Stephen H Petersdorf; Cathryn Rankin; David R Head; Howard R Terebelo; Cheryl L Willman; Stanley P Balcerzak; Anand Karnad; Shaker R Dakhil; Frederick R Appelbaum
Phase II evaluation of an intensified induction therapy with standard daunomycin and cytarabine followed by high dose cytarabine for adults with previously untreated acute myeloid leukemia: a Southwest Oncology Group study (SWOG-9500).
American journal of hematology 2007;82(12):1056-62.
2007: Frederick R Appelbaum
Hematopoietic-cell transplantation at 50.
The New England journal of medicine 2007;357(15):1472-5.
2007: Mohamed L Sorror; Brenda M Sandmaier; Barry E Storer; Michael B Maris; Frédéric Baron; David G Maloney; Bart L Scott; H Joachim Deeg; Frederick R Appelbaum; Rainer Storb
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Stanley R Riddell; Frederick R Appelbaum
Graft-versus-host disease: a surge of developments.
PLoS medicine 2007;4(7):e198.
2007: Daniel J DeAngelo; Daohai Yu; Jeffrey L Johnson; Steven E Coutre; Richard M Stone; Alison T Stopeck; Jon P Gockerman; Beverly S Mitchell; Frederick R Appelbaum; Richard A Larson
Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801.
Blood 2007;109(12):5136-42.
2007: Roland B Walter; Theodore A Gooley; V H J van der Velden; Michael R Loken; Jacques J M van Dongen; David A Flowers; Irwin D Bernstein; Frederick R Appelbaum
CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.
Blood 2007;109(10):4168-70.
2007: Ajay K Gopal; Joseph G Rajendran; Theodore A Gooley; John M Pagel; Darrell R Fisher; Stephen H Petersdorf; David G Maloney; Janet F Eary; Frederick R Appelbaum; Oliver W Press
High-dose [131I]tositumomab (anti-CD20) radioimmunotherapy and autologous hematopoietic stem-cell transplantation for adults > or = 60 years old with relapsed or refractory B-cell lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(11):1396-402.
2007: Paul A Carpenter; David S Snyder; Mary E D Flowers; Jean E Sanders; Theodore A Gooley; Paul J Martin; Frederick R Appelbaum; Jerald P Radich
Prophylactic administration of imatinib after hematopoietic cell transplantation for high-risk Philadelphia chromosome-positive leukemia.
Blood 2007;109(7):2791-3.
2007: Frederick R Appelbaum
Hematopoietic cell transplantation from unrelated donors for treatment of patients with acute myeloid leukemia in first complete remission.
Best practice & research. Clinical haematology 2007;20(1):67-75.
2007: Daniella M B Kerbauy; Theodore A Gooley; George E Sale; Mary E D Flowers; Kristine C Doney; George E Georges; Joanne E Greene; Michael Linenberger; Effie W Petersdorf; Brenda M Sandmaier; Bart L Scott; Mohamed L Sorror; Derek L Stirewalt; F Marc Stewart; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2007: Frederick R Appelbaum; Daniel Rosenblum; Robert J Arceci; William L Carroll; Philip P Breitfeld; Stephen J Forman; Richard A Larson; Stephanie J Lee; Sharon B Murphy; Susan O'Brien; Jerald P Radich; Nancy S Scher; Franklin O Smith; Richard M Stone; Martin S Tallman
End points to establish the efficacy of new agents in the treatment of acute leukemia.
Blood 2007;109(5):1810-6.
2007: Vivian G Oehler; Ted Gooley; David S Snyder; Laura Johnston; Allen Lin; Carrie C Cummings; Su Chu; Ravi Bhatia; Stephen J Forman; Robert S Negrin; Frederick R Appelbaum; Jerald P Radich
The effects of imatinib mesylate treatment before allogeneic transplantation for chronic myeloid leukemia.
Blood 2007;109(4):1782-9.
2006: Frederick R Appelbaum; Kenneth J Kopecky; Martin S Tallman; Marilyn L Slovak; Holly Gundacker; Haesook T Kim; Gordon W Dewald; Hagop M Kantarjian; Sherry R Pierce; Elihu H Estey
The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations.
British journal of haematology 2006;135(2):165-73.
2006: Carla S Wilson; George S Davidson; Shawn B Martin; Erik Andries; Jeffrey Potter; Richard Harvey; Kerem Ar; Yuexian Xu; Kenneth J Kopecky; Donna Pauler Ankerst; Holly Gundacker; Marilyn L Slovak; Monica Mosquera-Caro; I-Ming Chen; Derek L Stirewalt; Maurice Murphy; Frederick A Schultz; Huining Kang; Xuefei Wang; Jerald P Radich; Frederick R Appelbaum; Susan R Atlas; John E Godwin; Cheryl L Willman
Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction.
Blood 2006;108(2):685-96.
2006: Ajay K Gopal; John M Pagel; Joseph G Rajendran; David G Maloney; Frederick R Appelbaum; Mohamed L Sorror; Brenda M Sandmaier; Rainer Storb; Oliver W Press
Improving the efficacy of reduced intensity allogeneic transplantation for lymphoma using radioimmunotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(7):697-702.
2006: Marilyn L Slovak; Holly Gundacker; C D Bloomfield; G Dewald; Frederick R Appelbaum; R A Larson; Martin S Tallman; john bennett; Derek L Stirewalt; Soheil Meshinchi; Cheryl L Willman; Yaddanapudi Ravindranath; Todd A Alonzo; A J Carroll; S C Raimondi; Nyla A Heerema
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignancies.
Leukemia 2006;20(7):1295-7.
2006: H Joachim Deeg; Barry E Storer; Michael Boeckh; Paul J Martin; Jeannine S McCune; David Myerson; Shelly Heimfeld; Mary E D Flowers; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Richard A Nash; Paul V O'Donnell; Jerald P Radich; Brenda M Sandmaier; Bart L Scott; Mohamed L Sorror; Edus H Warren; Robert P Witherspoon; Ann Woolfrey; Frederick R Appelbaum; Rainer Storb
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Frederick R Appelbaum; Holly Gundacker; David R Head; Marilyn L Slovak; Cheryl L Willman; John E Godwin; Jeanne E Anderson; Stephen H Petersdorf
Age and acute myeloid leukemia.
Blood 2006;107(9):3481-5.
2006: John M Pagel; Frederick R Appelbaum; Janet F Eary; Joseph G Rajendran; Darrell R Fisher; Ted Gooley; Katherine Ruffner; Eneida R Nemecek; Eileen Sickle; Lawrence D Durack; Jeanette Carreras; Mary M Horowitz; Oliver W Press; Ajay K Gopal; Paul J Martin; Irwin D Bernstein; Dana C Matthews
131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission.
Blood 2006;107(5):2184-91.
2006: Frederick R Appelbaum; S Frieda Pearce
Hematopoietic cell transplantation in first complete remission versus early relapse.
Best practice & research. Clinical haematology 2006;19(2):333-9.
2006: Margaret R O'Donnell; Frederick R Appelbaum; Maria R Baer; John C Byrd; Steven E Coutre; Lloyd E Damon; Harry P Erba; Eli Estey; James Foran; Jeffrey Lancet; Lori J Maness; Peter Maslak; Michael Millenson; Joseph O Moore; Donna Przepiorka; Paul Shami; B Douglas Smith; Richard M Stone; Martin S Tallman
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):16-36.
2006: Renata E Zaucha; Dean C Buckner; Todd Barnett; Leona A Holmberg; Ted Gooley; Heather A Hooper; David G Maloney; Frederick R Appelbaum; William I Bensinger
Modified total body irradiation as a planned second high-dose therapy with stem cell infusion for patients with bone-based malignancies.
International journal of radiation oncology, biology, physics 2006;64(1):227-34.
2005: Roland B Walter; Jason L Pirga; Michelle cronk; Sasha Mayer; Frederick R Appelbaum; Deborah E Banker
PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism.
Blood 2005;106(10):3584-93.
2005: Mohamad A Hussein; Holly Gundacker; David R Head; Laurence Elias; K A Foon; David H Boldt; SM Dobin; Shaker R Dakhil; G T Budd; Frederick R Appelbaum
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
Leukemia 2005;19(11):1880-6.
2005: Richard A Larson; Eric L Sievers; Edward A Stadtmauer; Bob Löwenberg; Elihu H Estey; Hervé Dombret; Matthias Theobald; Dimitris Voliotis; John M Bennett; Maria Richie; Lance H Leopold; Mark S Berger; Matthew L Sherman; Michael R Loken; Jacques J M van Dongen; Irwin D Bernstein; Frederick R Appelbaum
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence.
Cancer 2005;104(7):1442-52.
2005: Daniella M B Kerbauy; Faith Chyou; Ted Gooley; Mohamed L Sorror; Bart Scott; John M Pagel; David Myerson; Frederick R Appelbaum; Rainer Storb; H Joachim Deeg
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):713-20.
2005: Richard A Nash; Laura Johnston; Pablo Parker; Jeannine S McCune; Barry Storer; John T Slattery; Terry Furlong; Claudio Anasetti; Frederick R Appelbaum; Michele E Lloid; H Joachim Deeg; Hans-Peter Kiem; Paul J Martin; Mark M Schubert; Robert P Witherspoon; Stephen J Forman; Karl G Blume; Rainer Storb
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: Paul A Carpenter; James Lowder; Laura Johnston; Haydar Frangoul; Hanna Khoury; Pablo Parker; Keith R Jerome; Jeannine S McCune; Barry Storer; Paul Martin; Frederick R Appelbaum; Rafat Abonour; Peter Westervelt; Claudio Anasetti
A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):465-71.
2005: Herschel Wallen; Theodore A Gooley; H Joachim Deeg; John M Pagel; Oliver W Press; Frederick R Appelbaum; Rainer Storb; Ajay K Gopal
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3439-46.
2005: Jean E Sanders; Ho Joon Im; Paul A Hoffmeister; Theodore A Gooley; Ann Woolfrey; Paul A Carpenter; Robert G Andrews; Eileen Bryant; Frederick R Appelbaum
Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.
Blood 2005;105(9):3749-56.
2005: Vivian G Oehler; Jerald P Radich; Barry Storer; Karl G Blume; Thomas R Chauncey; Reginald Clift; David S Snyder; Stephen J Forman; Mary E D Flowers; Paul Martin; Katherine A Guthrie; Robert S Negrin; Frederick R Appelbaum; William I Bensinger
Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2):85-92.
2005: Frederick R Appelbaum
Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation.
Leukemia 2005;19(2):171-5.
2005: Mary E D Flowers; F Traina; Barry Storer; Michael B Maris; Wolfgang A Bethge; Paul Carpenter; Frederick R Appelbaum; Rainer Storb; Brenda M Sandmaier; Paul J Martin
Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning.
Bone marrow transplantation 2005;35(3):277-82.
2005: Jean E Sanders; Katherine A Guthrie; Paul A Hoffmeister; Ann Woolfrey; Paul A Carpenter; Frederick R Appelbaum
Final adult height of patients who received hematopoietic cell transplantation in childhood.
Blood 2005;105(3):1348-54.
2005: Eneida R Nemecek; Donald K Hamlin; Darrell R Fisher; Kenneth A Krohn; John M Pagel; Frederick R Appelbaum; Oliver W Press; Dana C Matthews
Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):787-94.
2005: William Tse; Derek L Stirewalt; Frederick R Appelbaum; Jerald P Radich; H Joachim Deeg; Ted Gooley
Increased AF1q gene expression in high-risk myelodysplastic syndrome.
British journal of haematology 2005;128(2):218-20.
2005: Bart L Scott; Barry Storer; Michael R Loken; Rainer Storb; Frederick R Appelbaum; H Joachim Deeg
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):65-73.
2004: Bart Scott; H Joachim Deeg; Barry Storer; Thomas R Chauncey; Stephen H Petersdorf; John Slattery; Frederick R Appelbaum
Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
Leukemia & lymphoma 2004;45(12):2409-17.
2004: Betty L Stewart; Barry Storer; Jan Storek; H Joachim Deeg; Rainer Storb; John A Hansen; Frederick R Appelbaum; Paul A Carpenter; Jean E Sanders; Hans-Peter Kiem; Richard A Nash; Effie W Petersdorf; Carina Moravec; A James Morton; Claudio Anasetti; Mary E D Flowers; Paul J Martin
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
2004: William Tse; Soheil Meshinchi; Todd A Alonzo; Derek L Stirewalt; Robert B Gerbing; William G Woods; Frederick R Appelbaum; Jerald P Radich
Elevated expression of the AF1q gene, an MLL fusion partner, is an independent adverse prognostic factor in pediatric acute myeloid leukemia.
Blood 2004;104(10):3058-63.
2004: H Joachim Deeg; Peter Y Z Jiang; Leona A Holmberg; Bart Scott; Effie W Petersdorf; Frederick R Appelbaum
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Leukemia research 2004;28(11):1177-80.
2004: Deborah E Banker; Sasha J Mayer; Henry Y Li; Cheryl L Willman; Frederick R Appelbaum; Richard A Zager
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells.
Blood 2004;104(6):1816-24.
2004: Paul J Martin; Ji Pei; Ted Gooley; Claudio Anasetti; Frederick R Appelbaum; Joachim Deeg; John A Hansen; Richard A Nash; Effie W Petersdorf; Rainer Storb; Victor Ghetie; John Schindler; Ellen S Vitetta
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(8):552-60.
2004: Roland B Walter; Brian W Raden; Michelle cronk; Irwin D Bernstein; Frederick R Appelbaum; Deborah E Banker
The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin.
Blood 2004;103(11):4276-84.
2004: Paul J Martin; George B McDonald; Jean E Sanders; Claudio Anasetti; Frederick R Appelbaum; H Joachim Deeg; Richard A Nash; Effie W Petersdorf; John A Hansen; Rainer Storb
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
2004: U Yusuf; Haydar Frangoul; Theodore A Gooley; Ann Woolfrey; Paul A Carpenter; Robert G Andrews; H Joachim Deeg; Frederick R Appelbaum; Claudio Anasetti; Rainer Storb; Jean E Sanders
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone marrow transplantation 2004;33(8):805-14.
2004: Sophia S B Randolph; Theodore A Gooley; Edus H Warren; Frederick R Appelbaum; Stanley R Riddell
Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.
Blood 2004;103(1):347-52.
2003: B Stewart; M Verdugo; Katherine A Guthrie; Frederick R Appelbaum; H Joachim Deeg
Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
British journal of haematology 2003;123(5):879-85.
2003: M Benesch; George B McDonald; M Schubert; Frederick R Appelbaum; H Joachim Deeg
Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.
Bone marrow transplantation 2003;32(11):1071-5.
2003: H Joachim Deeg; Theodore A Gooley; Mary E D Flowers; George E Sale; John T Slattery; Claudio Anasetti; Thomas R Chauncey; Kristine C Doney; George E Georges; Hans-Peter Kiem; Paul J Martin; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Brenda M Sandmaier; Edus H Warren; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: David G Maloney; Arthur J Molina; Firoozeh Sahebi; Keith E Stockerl-Goldstein; Brenda M Sandmaier; William I Bensinger; Barry Storer; Ute Hegenbart; George Somlo; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Karl G Blume; Stephen J Forman; Peter McSweeney; Rainer Storb
Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma.
Blood 2003;102(9):3447-54.
2003: Ajay K Gopal; Theodore A Gooley; David G Maloney; Stephen H Petersdorf; Janet F Eary; Joseph G Rajendran; Sharon A Bush; Lawrence D Durack; Jane Golden; Paul J Martin; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein; Oliver W Press
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis.
Blood 2003;102(7):2351-7.
2003: Chien-Shing Chen; Michael Boeckh; K Seidel; Joan G Clark; E Kansu; David K Madtes; JL Wagner; Robert P Witherspoon; Claudio Anasetti; Frederick R Appelbaum; William I Bensinger; H Joachim Deeg; Paul J Martin; Jean E Sanders; Rainer Storb; Jan Storek; J Wade; MF Siadak; Mary E D Flowers; Keith M Sullivan
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
2003: F Gutierrez-Delgado; Leona A Holmberg; Heather A Hooper; Stephen H Petersdorf; Oliver W Press; Richard T Maziarz; David Maloney; Thomas R Chauncey; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen.
Bone marrow transplantation 2003;32(3):279-85.
2003: Kristine C Doney; Hans Hägglund; Wendy Leisenring; Thomas R Chauncey; Frederick R Appelbaum; Rainer Storb
Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(7):472-81.
2003: Jerald P Radich; Ted Gooley; William I Bensinger; Thomas R Chauncey; Reginald Clift; Mary Flowers; Paul Martin; John Slattery; Debbie Sultan; Frederick R Appelbaum
HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen.
Blood 2003;102(1):31-5.
2003: Henry Y Li; Frederick R Appelbaum; Cheryl L Willman; Richard A Zager; Deborah E Banker
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses.
Blood 2003;101(9):3628-34.
2003: Derek L Stirewalt; Katherine A Guthrie; Lan Beppu; Eileen Bryant; Kristine C Doney; Ted Gooley; Frederick R Appelbaum; Jerald P Radich
Predictors of relapse and overall survival in Philadelphia chromosome-positive acute lymphoblastic leukemia after transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003;9(3):206-12.
2003: Eric D Hsi; Kenneth J Kopecky; Frederick R Appelbaum; David H Boldt; Tom Frey; Margaret Loftus; Mohamad A Hussein
Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia.
British journal of haematology 2003;120(6):1017-25.
2003: Frederick R Appelbaum
New targets for therapy in acute myeloid leukemia.
Leukemia 2003;17(3):492-5.
2003: Derek L Stirewalt; Frederick R Appelbaum; Cheryl L Willman; Richard A Zager; Deborah E Banker
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression.
Leukemia research 2003;27(2):133-45.
2003: Lyle Feinstein; Brenda M Sandmaier; Ute Hegenbart; Peter A McSweeney; David G Maloney; Theodore A Gooley; Michael B Maris; Thomas R Chauncey; Benedetto Bruno; Frederick R Appelbaum; Dietger Niederwieser; Rainer F Storb
Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission.
British journal of haematology 2003;120(2):281-8.
2003: Frederick R Appelbaum
The current status of hematopoietic cell transplantation.
Annual review of medicine 2003;54():491-512.
2002: Jeanne E Anderson; Kenneth J Kopecky; Cheryl L Willman; David Head; Margaret R O'Donnell; Frederick W Luthardt; Thomas H Norwood; I-Ming Chen; Stanley P Balcerzak; David B Johnson; Frederick R Appelbaum
Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.
Blood 2002;100(12):3869-76.
2002: Richard A Larson; M Boogaerts; E Estey; Chatchada Karanes; Edward A Stadtmauer; Eric L Sievers; P Mineur; John M Bennett; Mark S Berger; Catharine B Eten; M Munteanu; Michael R Loken; Jacques J M van Dongen; Irwin D Bernstein; Frederick R Appelbaum
Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).
Leukemia 2002;16(9):1627-36.
2002: Alan F List; Kenneth J Kopecky; Cheryl L Willman; David R Head; Marilyn L Slovak; Dan Douer; Shaker R Dakhil; Frederick R Appelbaum
Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase.
Blood 2002;100(5):1910-2.
2002: H Joachim Deeg; Barry Storer; John T Slattery; Claudio Anasetti; Kristine C Doney; John A Hansen; Hans-Peter Kiem; Paul J Martin; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Howard M Shulman; Edus H Warren; Robert P Witherspoon; Eileen Bryant; Thomas R Chauncey; Lisa Getzendaner; Rainer Storb; Frederick R Appelbaum
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Jeannine S McCune; Ted Gooley; John P Gibbs; Jean E Sanders; Effie W Petersdorf; Frederick R Appelbaum; Claudio Anasetti; Linda Risler; Debbie Sultan; John T Slattery
Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2002;30(3):167-73.
2002: Mary E D Flowers; Pablo M Parker; Laura J Johnston; Alice V B Matos; Barry Storer; William I Bensinger; Rainer Storb; Frederick R Appelbaum; Stephen J Forman; Karl G Blume; Paul J Martin
Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial.
Blood 2002;100(2):415-9.
2002: Uwe Platzbecker; Ted Gooley; Claudio Anasetti; Frederick R Appelbaum; Bruce E Clurman; Kristine C Doney; Thomas R Chauncey; Mary E D Flowers; David Myerson; Jerald P Radich; Rainer Storb; Robert P Witherspoon; H Joachim Deeg
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Sibel Koc; Wendy Leisenring; Mary E D Flowers; Claudio Anasetti; H Joachim Deeg; Richard A Nash; Jean E Sanders; Robert P Witherspoon; Rainer Storb; Frederick R Appelbaum; Paul J Martin
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
2002: Sandra R Wolman; Holly Gundacker; Frederick R Appelbaum; Marilyn L Slovak
Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study.
Blood 2002;100(1):29-35.
2002: Kristine C Doney; Thomas R Chauncey; Frederick R Appelbaum
Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia.
Bone marrow transplantation 2002;29(10):817-23.
2002: John M Pagel; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein; Oliver W Press
The use of radioimmunoconjugates in stem cell transplantation.
Bone marrow transplantation 2002;29(10):807-16.
2002: Ajay K Gopal; Joseph G Rajendran; Stephen H Petersdorf; David G Maloney; Janet F Eary; Brent L Wood; Theodore A Gooley; Sharon A Bush; Lawrence D Durack; Paul J Martin; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein; Oliver W Press
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma.
Blood 2002;99(9):3158-62.
2002: Paul A Carpenter; Frederick R Appelbaum; Lawrence Corey; H Joachim Deeg; Kristine C Doney; Ted Gooley; James Krueger; Paul Martin; Sandra Pavlovic; Jean Sanders; John Slattery; Daniel Levitt; Rainer Storb; Ann Woolfrey; Claudio Anasetti
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Frederick R Appelbaum
Hematopoietic cell transplantation as a form of immunotherapy.
International journal of hematology 2002;75(3):222-7.
2002: Ann Woolfrey; Claudio Anasetti; Barry Storer; Kristine C Doney; Laurie A Milner; Eric L Sievers; Paul Carpenter; Paul Martin; Effie W Petersdorf; Frederick R Appelbaum; John A Hansen; Jean E Sanders
Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children.
Blood 2002;99(6):2002-8.
2002: H Joachim Deeg; J Gotlib; C Beckham; Kathleen Dugan; L Holmberg; M Schubert; Frederick R Appelbaum; P Greenberg
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study.
Leukemia 2002;16(2):162-4.
2002: Frederick R Appelbaum
Hematopoietic cell transplantation beyond first remission.
Leukemia 2002;16(2):157-9.
2002: Terry Furlong; Wendy Leisenring; Rainer Storb; Claudio Anasetti; Frederick R Appelbaum; Paul A Carpenter; H Joachim Deeg; Kristine C Doney; Hans-Peter Kiem; Richard A Nash; Jean E Sanders; Robert P Witherspoon; Dianne Thompson; Paul J Martin
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2002: Deborah E Banker; John J Cooper; Dean A Fennell; Cheryl L Willman; Frederick R Appelbaum; Finbarr E Cotter
PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism.
Leukemia research 2002;26(1):91-106.
2001: A I Benito; Terry Furlong; Paul J Martin; Claudio Anasetti; Frederick R Appelbaum; Kristine C Doney; Richard A Nash; T Papayannopoulou; Rainer Storb; Keith M Sullivan; Robert P Witherspoon; H Joachim Deeg
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: E Kansu; Ted Gooley; Mary E D Flowers; Claudio Anasetti; H Joachim Deeg; Richard A Nash; Jean E Sanders; Robert P Witherspoon; Frederick R Appelbaum; Rainer Storb; Paul J Martin
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
2001: Jan Storek; Ansamma Joseph; German Espino; Monja A Dawson; D C Douek; Keith M Sullivan; Mary E D Flowers; P Martin; G Mathioudakis; Richard A Nash; Rainer Storb; Frederick R Appelbaum; David G Maloney
Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation.
Blood 2001;98(13):3505-12.
2001: Alan F List; Kenneth J Kopecky; Cheryl L Willman; David R Head; Diane L Persons; Marilyn L Slovak; R Dorr; Chatchada Karanes; HE Hynes; James Doroshow; M Shurafa; Frederick R Appelbaum
Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study.
Blood 2001;98(12):3212-20.
2001: Jerald P Radich; Ted Gooley; Eileen Bryant; Thomas R Chauncey; Reginald Clift; Lan Beppu; S Edmands; Mary E D Flowers; K Kerkof; R Nelson; Frederick R Appelbaum
The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation.
Blood 2001;98(6):1701-7.
2001: F Gutierrez-Delgado; David G Maloney; Oliver W Press; J Golden; Leona A Holmberg; Richard T Maziarz; Heather A Hooper; C Dean Buckner; Frederick R Appelbaum; William I Bensinger
Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens.
Bone marrow transplantation 2001;28(5):455-61.
2001: Michael L Linenberger; T Hong; David A Flowers; Eric L Sievers; Theodore A Gooley; John M Bennett; Mark S Berger; Lance H Leopold; Frederick R Appelbaum; Irwin D Bernstein
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin.
Blood 2001;98(4):988-94.
2001: Jeanne E Anderson; Ayalew Tefferi; F Craig; L Holmberg; Thomas R Chauncey; Frederick R Appelbaum; Philippe Guardiola; Natalie S Callander; Cesar O Freytes; Yair Gazitt; B Razvillas; H J Deeg
Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis.
Blood 2001;98(3):586-93.
2001: Frederick R Appelbaum
Perspectives on the future of chronic myeloid leukemia treatment.
Seminars in hematology 2001;38(3 Suppl 8):35-42.
2001: Eric L Sievers; Richard A Larson; Edward A Stadtmauer; E Estey; Bob Löwenberg; Hervé Dombret; Chatchada Karanes; M Theobald; John M Bennett; Matthew L Sherman; Mark S Berger; Catharine B Eten; Michael R Loken; Jacques J M van Dongen; Irwin D Bernstein; Frederick R Appelbaum
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(13):3244-54.
2001: Derek L Stirewalt; Kenneth J Kopecky; Soheil Meshinchi; Frederick R Appelbaum; Marilyn L Slovak; Cheryl L Willman; Jerald P Radich
FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.
Blood 2001;97(11):3589-95.
2001: Peter A McSweeney; Dietger Niederwieser; Judith A Shizuru; Brenda M Sandmaier; A J Molina; David G Maloney; Thomas R Chauncey; Theodore A Gooley; Ute Hegenbart; Richard A Nash; Jerald P Radich; JL Wagner; S Minor; Frederick R Appelbaum; William I Bensinger; Eileen Bryant; Mary E D Flowers; George E Georges; F Carl Grumet; Hans-Peter Kiem; Beverly Torok-Storb; Cong Yu; Karl G Blume; Rainer Storb
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects.
Blood 2001;97(11):3390-400.
2001: Jan Storek; Monja A Dawson; Barry Storer; Terry Stevens-Ayers; David G Maloney; Kieren Marr; Robert P Witherspoon; William I Bensinger; Mary E D Flowers; P Martin; Rainer Storb; Frederick R Appelbaum; Michael Boeckh
Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation.
Blood 2001;97(11):3380-9.
2001: Frederick R Appelbaum
Haematopoietic cell transplantation as immunotherapy.
Nature 2001;411(6835):385-9.
2001: H Al-Ghamdi; Wendy Leisenring; W I Bensinger; Richard A Nash; Rainer Storb; Frederick R Appelbaum; Paul J Martin
A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest.
British journal of haematology 2001;113(2):461-9.
2001: Scott D Rowley; G Donaldson; Kathy Lilleby; William I Bensinger; Frederick R Appelbaum
Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation.
Blood 2001;97(9):2541-8.
2001: Robert P Witherspoon; H Joachim Deeg; Barry Storer; Claudio Anasetti; Rainer Storb; Frederick R Appelbaum
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2134-41.
2001: Frederick R Appelbaum
Who should be transplanted for AML?
Leukemia 2001;15(4):680-2.
2001: SM Garrido; Frederick R Appelbaum; Cheryl L Willman; Deborah E Banker
Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
Experimental hematology 2001;29(4):448-57.
2001: Ajay K Gopal; Theodore A Gooley; J B Golden; David G Maloney; William I Bensinger; Stephen H Petersdorf; Frederick R Appelbaum; Oliver W Press
Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older.
Bone marrow transplantation 2001;27(6):593-9.
2001: Stephen H Petersdorf; Kenneth J Kopecky; David R Head; David H Boldt; Stanley P Balcerzak; Ted Wun; V Roy; R W Veith; Frederick R Appelbaum
Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group Study.
Leukemia 2001;15(2):208-16.
2001: M Jurado; H Joachim Deeg; Ted Gooley; Claudio Anasetti; Thomas R Chauncey; Mary Flowers; David Myerson; Rainer Storb; Frederick R Appelbaum
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: William I Bensinger; Paul J Martin; Barry Storer; Reginald Clift; Stephen J Forman; Robert S Negrin; A Kashyap; Mary E D Flowers; Kathy Lilleby; Thomas R Chauncey; Rainer Storb; Frederick R Appelbaum
Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers.
The New England journal of medicine 2001;344(3):175-81.
2001: Frederick R Appelbaum; J M Rowe; Jerald P Radich; J E Dick
Acute myeloid leukemia.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2001;():62-86.
2001: Jeanne E Anderson; Frederick R Appelbaum; Gary Schoch; T Barnett; Thomas R Chauncey; M E Flowers; Rainer Storb
Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(3):163-70.
2001: Rainer Storb; Karl G Blume; Margaret R O'Donnell; Thomas R Chauncey; Stephen J Forman; H Joachim Deeg; Wendy W Hu; Frederick R Appelbaum; Kristine C Doney; Mary E D Flowers; Jean Sanders; Wendy Leisenring
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2001: SM Garrido; J J Cooper; Frederick R Appelbaum; Cheryl L Willman; K Kopecky; Deborah E Banker
Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis.
Leukemia research 2001;25(1):23-32.
2000: Marilyn L Slovak; Kenneth J Kopecky; Peter A Cassileth; D H Harrington; K S Theil; Anwar N Mohamed; Elisabeth Paietta; Cheryl L Willman; David R Head; Jacob M Rowe; Stephen J Forman; Frederick R Appelbaum
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.
Blood 2000;96(13):4075-83.
2000: Sibel Koc; Wendy Leisenring; Mary E D Flowers; Claudio Anasetti; H Joachim Deeg; Richard A Nash; Jean E Sanders; Robert P Witherspoon; Frederick R Appelbaum; Rainer Storb; Paul J Martin
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
2000: Frederick R Appelbaum; Maria R Baer; M H Carabasi; Steven E Coutre; Harry P Erba; Eli Estey; MJ Glenn; E H Kraut; Peter Maslak; Michael Millenson; Carole B Miller; Hussain I Saba; R Stone; Martin S Tallman
NCCN Practice Guidelines for Acute Myelogenous Leukemia.
Oncology (Williston Park, N.Y.) 2000;14(11A):53-61.
2000: Terry Furlong; Rainer Storb; Claudio Anasetti; Frederick R Appelbaum; H Joachim Deeg; Kristine C Doney; Paul Martin; K Sullivan; Robert P Witherspoon; Richard A Nash
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
2000: Oliver W Press; Janet F Eary; Ted Gooley; Ajay K Gopal; S Liu; Joseph G Rajendran; David G Maloney; Stephen H Petersdorf; Sharon A Bush; Lawrence D Durack; Paul J Martin; Darrell R Fisher; Brent Wood; J W Borrow; B Porter; J P Smith; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas.
Blood 2000;96(9):2934-42.
2000: Sibel Koc; H Hagglund; R C Ireton; J A Perez-Simon; S J Collins; Frederick R Appelbaum
Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation.
Bone marrow transplantation 2000;26(8):899-901.
2000: J Sierra; Barry Storer; J A Hansen; Paul J Martin; E W Petersdorf; A Woolfrey; D Matthews; Jean E Sanders; Rainer Storb; Frederick R Appelbaum; Claudio Anasetti
Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience.
Bone marrow transplantation 2000;26(4):397-404.
2000: H Joachim Deeg; Frederick R Appelbaum
Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Leukemia research 2000;24(8):653-63.
2000: D Y Zang; H Joachim Deeg; Ted Gooley; Jeanne E Anderson; Claudio Anasetti; Jean Sanders; David Myerson; Rainer Storb; Frederick R Appelbaum
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
British journal of haematology 2000;110(1):217-22.
2000: F Gutierrez-Delgado; Leona A Holmberg; Heather A Hooper; Frederick R Appelbaum; R B Livingston; Richard T Maziarz; P Weiden; Saul E Rivkin; P Montgomery; K Kawahara; William I Bensinger
High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer.
Bone marrow transplantation 2000;26(1):51-9.
2000: T R Chauncey; C Rankin; Jeanne E Anderson; I Chen; Kenneth J Kopecky; J E Godwin; M E Kalaycio; D F Moore; M S Shurafa; Stephen H Petersdorf; Eric H Kraut; CP Leith; David R Head; Frederick W Luthardt; Cheryl L Willman; Frederick R Appelbaum
A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest oncology group study 9617.
Leukemia research 2000;24(7):567-74.
2000: SM Garrido; Eileen Bryant; Frederick R Appelbaum
Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities.
Leukemia research 2000;24(6):481-6.
2000: SM Garrido; Cheryl L Willman; Frederick R Appelbaum; Deborah E Banker
Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Cytometry 2000;42(2):83-94.
2000: P J Rosen; C Rankin; David R Head; David H Boldt; Frederick W Luthardt; Thomas H Norwood; R P Pugh; Chatchada Karanes; Frederick R Appelbaum
A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia.
Leukemia research 2000;24(3):183-7.
2000: Frederick R Appelbaum
Is there a best transplant conditioning regimen for acute myeloid leukemia?
Leukemia 2000;14(3):497-501.
2000: H Joachim Deeg; Howard M Shulman; Jeanne E Anderson; Eileen Bryant; Theodore A Gooley; John T Slattery; Claudio Anasetti; Alexander Fefer; Rainer Storb; Frederick R Appelbaum
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Mary E D Flowers; Wendy Leisenring; K Beach; Stanley R Riddell; Jerald P Radich; C S Higano; Scott D Rowley; Thomas R Chauncey; Jean E Sanders; Claudio Anasetti; Rainer Storb; J Wade; Frederick R Appelbaum; Paul Martin
Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3A):321-6.
2000: J P Radich; T Gooley; J E Sanders; Claudio Anasetti; T Chauncey; Frederick R Appelbaum
Second allogeneic transplantation after failure of first autologous transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(3):272-9.
2000: Richard A Nash; R Kurzrock; John DiPersio; Julie M Vose; Charles Linker; D Maharaj; Auayporn Nademanee; R Negrin; Stephen D Nimer; Howard M Shulman; Mark Ashby; Denny Jones; Frederick R Appelbaum; Richard Champlin
A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000;6(1):25-34.
2000: A M Cavallaro; Kathy Lilleby; Ignazio Majolino; Rainer Storb; Frederick R Appelbaum; Scott D Rowley; William I Bensinger
Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
Bone marrow transplantation 2000;25(1):85-9.
1999: Leona A Holmberg; Michael Boeckh; Heather A Hooper; Wendy Leisenring; Scott D Rowley; Shelly Heimfeld; Oliver W Press; David G Maloney; Peter McSweeney; Lawrence Corey; Richard T Maziarz; Frederick R Appelbaum; William I Bensinger
Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.
Blood 1999;94(12):4029-35.
1999: Reginald Clift; Jerald P Radich; Frederick R Appelbaum; Paul Martin; Mary E D Flowers; H Joachim Deeg; Rainer Storb; ED Thomas
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.
Blood 1999;94(11):3960-2.
1999: Frederick R Appelbaum
Molecular diagnosis and clinical decisions in adult acute leukemia.
Seminars in hematology 1999;36(4):401-10.
1999: Frederick R Appelbaum
Antibody-targeted therapy for myeloid leukemia.
Seminars in hematology 1999;36(4 Suppl 6):2-8.
1999: Paul J Martin; Scott D Rowley; Claudio Anasetti; Thomas R Chauncey; Ted Gooley; Effie W Petersdorf; Jo-Anne H van Burik; Mary E D Flowers; Rainer Storb; Frederick R Appelbaum; John A Hansen
A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients.
Blood 1999;94(7):2192-9.
1999: Chatchada Karanes; Kenneth J Kopecky; David R Head; Michael R Grever; HE Hynes; Eric H Kraut; R H Vial; A Lichtin; S Nand; W E Samlowski; Frederick R Appelbaum
A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study.
Leukemia research 1999;23(9):787-94.
1999: Dana C Matthews; Frederick R Appelbaum; Janet F Eary; Darrell R Fisher; Lawrence D Durack; T E Hui; Paul J Martin; D Mitchell; Oliver W Press; Rainer Storb; Irwin D Bernstein
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome.
Blood 1999;94(4):1237-47.
1999: CP Leith; Kenneth J Kopecky; I-Ming Chen; L Eijdems; Marilyn L Slovak; T S McConnell; David R Head; J Weick; Michael R Grever; Frederick R Appelbaum; Cheryl L Willman
Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study.
Blood 1999;94(3):1086-99.
1999: Frederick R Appelbaum
Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue.
Blood 1999;94(2):381-3.
1999: Derek L Stirewalt; Bruce E Clurman; Frederick R Appelbaum; Cheryl L Willman; Jerald P Radich
p73 mutations and expression in adult de novo acute myelogenous leukemia.
Leukemia 1999;13(7):985-90.
1999: John P Gibbs; Ted Gooley; B Corneau; G Murray; P Stewart; Frederick R Appelbaum; John T Slattery
The impact of obesity and disease on busulfan oral clearance in adults.
Blood 1999;93(12):4436-40.
1999: Eric L Sievers; Frederick R Appelbaum; R T Spielberger; Stephen J Forman; David A Flowers; Franklin O Smith; Kathleen Shannon Dorcy; Mark S Berger; Irwin D Bernstein
Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate.
Blood 1999;93(11):3678-84.
1999: Dana C Matthews; Paul J Martin; Cynthia Nourigat; Frederick R Appelbaum; Darrell R Fisher; Irwin D Bernstein
Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.
Blood 1999;93(2):737-45.
1999: Rainer Storb; R F Raff; T Graham; Frederick R Appelbaum; H Joachim Deeg; Friedrich Schuening; George E Sale; K Seidel
Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):155-61.
1998: Peter A Cassileth; David Harrington; Frederick R Appelbaum; Hillard M Lazarus; Jacob M Rowe; Elisabeth Paietta; Cheryl L Willman; D D Hurd; John M Bennett; K G Blume; David R Head; Peter H Wiernik
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission.
The New England journal of medicine 1998;339(23):1649-56.
1998: Deborah E Banker; Jerald P Radich; A Becker; K Kerkof; Thomas H Norwood; Cheryl L Willman; Frederick R Appelbaum
The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(12):3051-62.
1998: Ann Woolfrey; Theodore A Gooley; Eric L Sievers; Laurie A Milner; Robert G Andrews; M Walters; Paul A Hoffmeister; John A Hansen; Claudio Anasetti; Eileen Bryant; Frederick R Appelbaum; Jean E Sanders
Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome.
Blood 1998;92(10):3546-56.
1998: Paul J Martin; Gary Schoch; Ted Gooley; Claudio Anasetti; H Joachim Deeg; Richard Nash; J Sanders; Rainer Storb; Frederick R Appelbaum
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
1998: Leona A Holmberg; Taner Demirer; Scott D Rowley; C Dean Buckner; G Goodman; Richard T Maziarz; JP Klarnet; N Zuckerman; G Harrer; R McCloskey; R Gersh; R Goldberg; W Nichols; A Jacobs; P Weiden; P Montgomery; Saul E Rivkin; Frederick R Appelbaum; William I Bensinger
High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III/IV ovarian cancer.
Bone marrow transplantation 1998;22(7):651-9.
1998: S Y Liu; Janet F Eary; Stephen H Petersdorf; Paul J Martin; David G Maloney; Frederick R Appelbaum; Dana C Matthews; Sharon A Bush; Lawrence D Durack; Darrell R Fisher; Theodore A Gooley; Irwin D Bernstein; Oliver W Press
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3270-8.
1998: Frederick R Appelbaum; J Anderson
Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score.
Leukemia 1998;12 Suppl 1():S25-9.
1998: Reginald Clift; C Dean Buckner; Frederick R Appelbaum; Keith M Sullivan; Rainer Storb; ED Thomas
Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia.
Blood 1998;92(4):1455-6.
1998: A J Morton; Ted Gooley; John A Hansen; Frederick R Appelbaum; Barbara Bruemmer; JW Bjerke; Reginald Clift; Paul J Martin; Effie W Petersdorf; Jean E Sanders; Rainer Storb; Keith M Sullivan; Ann Woolfrey; Claudio Anasetti
Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.
Blood 1998;92(2):394-401.
1998: Keith M Sullivan; Claudio Anasetti; M Horowitz; P A Rowlings; Effie W Petersdorf; Paul J Martin; Reginald Clift; MC Walters; Ted Gooley; J Sierra; Jeanne E Anderson; JW Bjerke; MF Siadak; Mary E D Flowers; Richard A Nash; Jean E Sanders; Frederick R Appelbaum; Rainer Storb; John A Hansen
Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant Registry.
Annals of the New York Academy of Sciences 1998;850():312-24.
1998: Scott D Rowley; Michael R Loken; Jerald P Radich; L A Kunkle; B J Mills; Ted Gooley; Leona A Holmberg; Peter McSweeney; K Beach; B MacLeod; Frederick R Appelbaum; William I Bensinger
Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system.
Bone marrow transplantation 1998;21(12):1253-62.
1998: John E Godwin; Kenneth J Kopecky; David R Head; Cheryl L Willman; CP Leith; HE Hynes; Stanley P Balcerzak; Frederick R Appelbaum
A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).
Blood 1998;91(10):3607-15.
1998: Frederick R Appelbaum; J Anderson
Bone marrow transplantation for myelodysplasia in adults and children: when and who?
Leukemia research 1998;22 Suppl 1():S35-9.
1998: Brenda M Sandmaier; Rainer Storb; K L Bennett; Frederick R Appelbaum; Erlinda B Santos
Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model.
Blood 1998;91(9):3494-502.
1998: John A Hansen; Theodore A Gooley; Paul J Martin; Frederick R Appelbaum; Thomas R Chauncey; Reginald Clift; Effie W Petersdorf; Jerald P Radich; Jean E Sanders; Rainer Storb; Keith M Sullivan; Claudio Anasetti
Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia.
The New England journal of medicine 1998;338(14):962-8.
1998: Deborah E Banker; Mark Groudine; Cheryl L Willman; Thomas H Norwood; Frederick R Appelbaum
Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents.
Leukemia research 1998;22(3):221-39.
1998: Rainer Storb; R Raff; H Joachim Deeg; T Graham; Frederick R Appelbaum; Friedrich Schuening; Howard M Shulman; K Seidel; Wendy Leisenring
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
International journal of radiation oncology, biology, physics 1998;40(4):961-6.
1998: P Martin; R Nash; J Sanders; Wendy Leisenring; C Anasetti; H Joachim Deeg; Rainer Storb; Frederick R Appelbaum
Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.
Bone marrow transplantation 1998;21(3):273-9.
1998: Keith M Sullivan; E Kansu; Barry Storer; J Jocom; G Emerson; T Reagan; M Vaughn Emerson; MF Siadak; C Davis; Frederick R Appelbaum; C Dean Buckner; John A Hansen; Howard M Shulman; Rainer Storb; George B McDonald
Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1998;4(1):20-6.
1997: Jan Storek; Ted Gooley; MF Siadak; William I Bensinger; D G Maloney; Thomas R Chauncey; Mary Flowers; Keith M Sullivan; Robert P Witherspoon; S D Rowley; John A Hansen; Rainer Storb; Frederick R Appelbaum
Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease.
Blood 1997;90(12):4705-9.
1997: C S Chen; K Seidel; J O Armitage; J W Fay; Frederick R Appelbaum; M M Horowitz; E J Shpall; P L Weiden; K S Antman; R E Champlin; J H Kersey; Keith M Sullivan
Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(6):331-40.
1997: K Schiffman; C Dean Buckner; Richard T Maziarz; David G Maloney; Frederick R Appelbaum; Oliver W Press; Ted Gooley; Leona A Holmberg; Kathy Lilleby; Reginald Clift; N Zuckerman; JP Klarnet; C Weaver; Thomas R Chauncey; William I Bensinger
High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(5):261-6.
1997: Friedrich Schuening; C von Kalle; H P Kiem; Frederick R Appelbaum; H Joachim Deeg; M Pepe; Ted Gooley; T C Graham; R C Hackman; R Storb
Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Experimental hematology 1997;25(12):1240-5.
1997: Rainer Storb; Wendy Leisenring; Claudio Anasetti; Frederick R Appelbaum; H Joachim Deeg; Kristine C Doney; Paul Martin; Keith M Sullivan; Robert P Witherspoon; Mary Pettinger; William I Bensinger; C Dean Buckner; Reginald Clift; Mary E D Flowers; John A Hansen; M Pepe; Thomas R Chauncey; Jean Sanders; ED Thomas
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Jorge Sierra; J Radich; John A Hansen; Paul J Martin; Effie W Petersdorf; JW Bjerke; Eileen Bryant; Richard A Nash; Jean E Sanders; Rainer Storb; Keith M Sullivan; Frederick R Appelbaum; Claudio Anasetti
Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Blood 1997;90(4):1410-4.
1997: J E Anderson; Frederick R Appelbaum
Myelodysplasia and myeloproliferative disorders.
Current opinion in hematology 1997;4(4):261-7.
1997: William I Bensinger; K S Schiffman; Leona A Holmberg; Frederick R Appelbaum; Richard T Maziarz; P Montgomery; E Ellis; Saul E Rivkin; P Weiden; Kathy Lilleby; Scott D Rowley; Stephen H Petersdorf; JP Klarnet; W Nichols; A Hertler; R McCroskey; Charles H Weaver; C Dean Buckner
High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer.
Bone marrow transplantation 1997;19(12):1183-9.
1997: Jorge Sierra; Barry Storer; John A Hansen; JW Bjerke; Paul J Martin; Effie W Petersdorf; Frederick R Appelbaum; Eileen Bryant; Thomas R Chauncey; George E Sale; Jean E Sanders; Rainer Storb; Keith M Sullivan; Claudio Anasetti
Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.
Blood 1997;89(11):4226-35.
1997: H Joachim Deeg; D Lin; Wendy Leisenring; Michael Boeckh; Claudio Anasetti; Frederick R Appelbaum; Thomas R Chauncey; Kristine C Doney; Mary Flowers; Paul Martin; Richard Nash; Gary Schoch; Keith M Sullivan; Robert P Witherspoon; Rainer Storb
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: Frederick R Appelbaum
Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL).
Leukemia 1997;11 Suppl 4():S15-7.
1997: CP Leith; Kenneth J Kopecky; John E Godwin; T McConnell; Marilyn L Slovak; I-Ming Chen; David R Head; Frederick R Appelbaum; Cheryl L Willman
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study.
Blood 1997;89(9):3323-9.
1997: John T Slattery; Reginald Clift; C Dean Buckner; Jerald P Radich; Barry Storer; William I Bensinger; E Soll; Claudio Anasetti; Raleigh Bowden; Eileen Bryant; Thomas R Chauncey; H Joachim Deeg; Kristine C Doney; Mary Flowers; Ted Gooley; John A Hansen; Paul J Martin; George B McDonald; Richard Nash; Effie W Petersdorf; Jean E Sanders; Gary Schoch; P Stewart; Rainer Storb; Keith M Sullivan; ED Thomas; Robert P Witherspoon; Frederick R Appelbaum
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Jerald P Radich; G Gehly; A Lee; R Avery; Eileen Bryant; S Edmands; Ted Gooley; P Kessler; J Kirk; Paula A Ladne; ED Thomas; Frederick R Appelbaum
Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation.
Blood 1997;89(7):2602-9.
1997: Jeanne E Anderson; Theodore A Gooley; Gary Schoch; Claudio Anasetti; William I Bensinger; Reginald Clift; John A Hansen; Jean E Sanders; Rainer Storb; Frederick R Appelbaum
Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy.
Blood 1997;89(7):2578-85.
1997: N Robinson; M C Benyunes; JA Thompson; A York; Stephen H Petersdorf; Oliver W Press; CG Lindgren; Thomas R Chauncey; C Dean Buckner; William I Bensinger; Frederick R Appelbaum; Alexander Fefer
Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study.
Bone marrow transplantation 1997;19(5):435-42.
1997: Taner Demirer; C Dean Buckner; Barry Storer; Kathy Lilleby; Scott D Rowley; Reginald Clift; Frederick R Appelbaum; Rainer Storb; William I Bensinger
Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):684-90.
1997: Frederick R Appelbaum
Allogeneic hematopoietic stem cell transplantation for acute leukemia.
Seminars in oncology 1997;24(1):114-23.
1997: Kristine C Doney; Wendy Leisenring; Rainer Storb; Frederick R Appelbaum
Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team.
Annals of internal medicine 1997;126(2):107-15.
1997: Dana C Matthews; Frederick R Appelbaum; Oliver W Press; Janet F Eary; Irwin D Bernstein
The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies.
Cancer treatment and research 1997;77():121-39.
1997: Deborah E Banker; Mark Groudine; Thomas H Norwood; Frederick R Appelbaum
Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia.
Blood 1997;89(1):243-55.
1996: T Tsai; S Davalath; C Rankin; Jerald P Radich; D Head; Frederick R Appelbaum; D H Boldt
Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory ALL treated in Southwest Oncology Group studies.
Leukemia 1996;10(12):1901-10.
1996: William I Bensinger; C Dean Buckner; Kathleen Shannon Dorcy; Scott D Rowley; Frederick R Appelbaum; M Benyunes; Reginald Clift; P Martin; Taner Demirer; Rainer Storb; M Lee; Gary J Schiller
Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.
Blood 1996;88(11):4132-8.
1996: M C Corcoran; Oliver W Press; Dana C Matthews; Frederick R Appelbaum; Irwin D Bernstein
The role of radioimmunotherapy in bone marrow transplantation.
Current opinion in hematology 1996;3(6):438-45.
1996: J K Weick; Kenneth J Kopecky; Frederick R Appelbaum; D R Head; L L Kingsbury; Stanley P Balcerzak; J N Bickers; HE Hynes; Jeanna Welborn; S R Simon; Michael R Grever
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study.
Blood 1996;88(8):2841-51.
1996: Ralf Huss; H Joachim Deeg; T Gooley; Eileen Bryant; Wendy Leisenring; Reginald Clift; C Dean Buckner; P Martin; Rainer Storb; Frederick R Appelbaum
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Bone marrow transplantation 1996;18(4):767-76.
1996: William I Bensinger; Reginald Clift; P Martin; Frederick R Appelbaum; Taner Demirer; T Gooley; Kathy Lilleby; Scott D Rowley; Jean Sanders; Rainer Storb; C Dean Buckner
Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.
Blood 1996;88(7):2794-800.
1996: William I Bensinger; C Dean Buckner; Claudio Anasetti; Reginald Clift; Rainer Storb; T Barnett; Thomas R Chauncey; Howard M Shulman; Frederick R Appelbaum
Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome.
Blood 1996;88(7):2787-93.
1996: P A McSweeney; Katherine A Rouleau; Rainer Storb; L Bolles; PM Wallace; M Beauchamp; L Krizanac-Bengez; Peter F Moore; George E Sale; Brenda M Sandmaier; T de Revel; Frederick R Appelbaum; Richard A Nash
Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein.
Blood 1996;88(6):1992-2003.
1996: William I Bensinger; Taner Demirer; C Dean Buckner; Frederick R Appelbaum; Rainer Storb; Kathy Lilleby; P Weiden; A Z Bluming; Alexander Fefer
Syngeneic marrow transplantation in patients with multiple myeloma.
Bone marrow transplantation 1996;18(3):527-31.
1996: Hans-Peter Kiem; Wendy Leisenring; R Raff; H Joachim Deeg; Friedrich Schuening; Frederick R Appelbaum; Rainer Storb
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.
Blood 1996;88(5):1896-7.
1996: Paul J Martin; B J Nelson; Frederick R Appelbaum; Claudio Anasetti; H Joachim Deeg; John A Hansen; George B McDonald; Richard A Nash; K M Sullivan; Robert P Witherspoon; PJ Scannon; N Friedmann; Rainer Storb
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
1996: M W Brunvand; William I Bensinger; E Soll; Charles H Weaver; Scott D Rowley; Frederick R Appelbaum; Kathy Lilleby; Reginald Clift; T A Gooley; Oliver W Press; Alexander Fefer; Rainer Storb; Jean E Sanders; P L Martin; Thomas R Chauncey; Richard T Maziarz; N Zuckerman; P Montgomery; R Dorn; P L Weiden; Taner Demirer; Leona A Holmberg; K Schiffman; P A McSweeney; C Dean Buckner
High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells.
Bone marrow transplantation 1996;18(1):131-41.
1996: K S Schiffman; William I Bensinger; Frederick R Appelbaum; Scott D Rowley; Kathy Lilleby; Reginald Clift; Charles H Weaver; Taner Demirer; Jean E Sanders; S Petersdorf; T Gooley; P Weiden; N Zuckerman; P Montgomery; Richard T Maziarz; J P Klarnet; Saul E Rivkin; K Trueblood; Rainer Storb; Leona A Holmberg; C Dean Buckner
Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease.
Bone marrow transplantation 1996;17(6):943-50.
1996: Taner Demirer; C Dean Buckner; T Gooley; Frederick R Appelbaum; Scott D Rowley; Thomas R Chauncey; Kathy Lilleby; Rainer Storb; William I Bensinger
Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma.
Bone marrow transplantation 1996;17(6):937-41.
1996: Hans-Peter Kiem; George B McDonald; David Myerson; C L Spurgeon; H Joachim Deeg; Jean E Sanders; Kristine C Doney; Frederick R Appelbaum; K M Sullivan; Robert P Witherspoon; Rainer Storb
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):93-9.
1996: M C Walters; M Patience; Wendy Leisenring; J R Eckman; G R Buchanan; Zora R Rogers; N E Olivieri; E Vichinsky; Sally C Davies; W C Mentzer; Darleen R Powars; J P Scott; F Bernaudin; K Ohene-Frempong; P J Darbyshire; ALAN WAYNE; Irene A G Roberts; P Dinndorf; S Brandalise; Jean E Sanders; Dana C Matthews; Frederick R Appelbaum; Rainer Storb; K M Sullivan
Barriers to bone marrow transplantation for sickle cell anemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):100-4.
1996: Taner Demirer; C Dean Buckner; Frederick R Appelbaum; Reginald Clift; Rainer Storb; David Myerson; Kathy Lilleby; Scott D Rowley; William I Bensinger
High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer.
Bone marrow transplantation 1996;17(5):769-74.
1996: John T Slattery; Thomas F Kalhorn; George B McDonald; K Lambert; C Dean Buckner; William I Bensinger; C Anasetti; Frederick R Appelbaum
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1484-94.
1996: William I Bensinger; Scott D Rowley; Taner Demirer; Kathy Lilleby; K Schiffman; Reginald Clift; Frederick R Appelbaum; Alexander Fefer; T Barnett; Rainer Storb; Thomas R Chauncey; Richard T Maziarz; J Klarnet; P McSweeney; Leona A Holmberg; David G Maloney; Charles H Weaver; C Dean Buckner
High-dose therapy followed by autologous hematopoietic stem-cell infusion for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1447-56.
1996: Oliver W Press; D Shan; J Howell-Clark; Janet F Eary; Frederick R Appelbaum; D Matthews; D J King; A M Haines; P Hamann; L Hinman; D Shochat; Irwin D Bernstein
Comparative metabolism and retention of iodine-125, yttrium-90, and indium-111 radioimmunoconjugates by cancer cells.
Cancer research 1996;56(9):2123-9.
1996: Taner Demirer; C Dean Buckner; Frederick R Appelbaum; William I Bensinger; Jean Sanders; K Lambert; Reginald Clift; Alexander Fefer; Rainer Storb; John T Slattery
Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(4):491-5.
1996: Jean E Sanders; J Hawley; W Levy; T Gooley; C Dean Buckner; H Joachim Deeg; Kristine C Doney; Rainer Storb; K Sullivan; Robert P Witherspoon; Frederick R Appelbaum
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: J E Anderson; Claudio Anasetti; Frederick R Appelbaum; Gary Schoch; T A Gooley; John A Hansen; C Dean Buckner; Jean E Sanders; K M Sullivan; Rainer Storb
Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia.
British journal of haematology 1996;93(1):59-67.
1996: William I Bensinger; C Dean Buckner; Scott D Rowley; Rainer Storb; Frederick R Appelbaum
Treatment of normal donors with recombinant growth factors for transplantation of allogeneic blood stem cells.
Bone marrow transplantation 1996;17 Suppl 2():S19-21.
1996: Taner Demirer; C Dean Buckner; Frederick R Appelbaum; K Lambert; William I Bensinger; Reginald Clift; Rainer Storb; John T Slattery
Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation in advanced acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels.
Bone marrow transplantation 1996;17(3):341-6.
1996: N Robinson; Jean E Sanders; M C Benyunes; K Beach; CG Lindgren; JA Thompson; Frederick R Appelbaum; Alexander Fefer
Phase I trial of interleukin-2 after unmodified HLA-matched sibling bone marrow transplantation for children with acute leukemia.
Blood 1996;87(4):1249-54.
1996: K M Sullivan; Jan Storek; K J Kopecky; J Jocom; Gary Longton; M Flowers; MF Siadak; J Nims; Robert P Witherspoon; Claudio Anasetti; Frederick R Appelbaum; Raleigh A Bowden; C Dean Buckner; SW Crawford; H Joachim Deeg; John A Hansen; George B McDonald; Jean E Sanders; Rainer Storb
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: M A Bean; T Graham; Frederick R Appelbaum; H Joachim Deeg; Friedrich Schuening; G E Sale; Wendy Leisenring; M Pepe; Rainer Storb
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.
Transplantation 1996;61(2):334-5.
1996: Richard A Nash; T Gooley; C Davis; Frederick R Appelbaum
The problem of thrombocytopenia after hematopoietic stem cell transplantation.
Stem cells (Dayton, Ohio) 1996;14 Suppl 1():261-73.
1996: J E Anderson; Frederick R Appelbaum; Gary Schoch; T Gooley; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Thomas R Chauncey; Reginald Clift
Allogeneic marrow transplantation for myelodysplastic syndrome with advanced disease morphology: a phase II study of busulfan, cyclophosphamide, and total-body irradiation and analysis of prognostic factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):220-6.
1996: J E Anderson; Frederick R Appelbaum; Gary Schoch; T Gooley; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Thomas R Chauncey; Reginald Clift; Kristine C Doney; M Flowers; John A Hansen; Paul J Martin; Dana C Matthews; Jean E Sanders; Howard M Shulman; K M Sullivan; Robert P Witherspoon; Rainer Storb
Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors.
Blood 1996;87(1):51-8.
1995: A Balduzzi; T Gooley; Claudio Anasetti; Jean E Sanders; Paul J Martin; Effie W Petersdorf; Frederick R Appelbaum; C Dean Buckner; D Matthews; Rainer Storb; K M Sullivan; John A Hansen
Unrelated donor marrow transplantation in children.
Blood 1995;86(8):3247-56.
1995: William I Bensinger; Frederick R Appelbaum; Scott D Rowley; Rainer Storb; Jean Sanders; Kathy Lilleby; T Gooley; Taner Demirer; K Schiffman; C Weaver
Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(10):2547-55.
1995: CP Leith; I-Ming Chen; Kenneth J Kopecky; Frederick R Appelbaum; D R Head; J E Godwin; J K Weick; Cheryl L Willman
Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR-/efflux+ and MDR1+/efflux- cases.
Blood 1995;86(6):2329-42.
1995: P Kalhs; I Schwarzinger; G Anderson; Motomi Mori; Reginald Clift; Rainer Storb; C Dean Buckner; Frederick R Appelbaum; John A Hansen; K M Sullivan
A retrospective analysis of the long-term effect of splenectomy on late infections, graft-versus-host disease, relapse, and survival after allogeneic marrow transplantation for chronic myelogenous leukemia.
Blood 1995;86(5):2028-32.
1995: Richard A Nash; S A Burstein; Rainer Storb; W Yang; K Abrams; Frederick R Appelbaum; T Boone; H Joachim Deeg; Lawrence D Durack; Friedrich Schuening
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
Blood 1995;86(5):1765-75.
1995: F L Meyskens; Kenneth J Kopecky; Frederick R Appelbaum; S P Balcerzak; W Samlowski; HE Hynes
Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial.
Leukemia research 1995;19(9):605-12.
1995: Oliver W Press; Janet F Eary; Frederick R Appelbaum; Paul J Martin; W B Nelp; S Glenn; D R Fisher; B Porter; Dana C Matthews; T Gooley
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.
Lancet 1995;346(8971):336-40.
1995: Frederick R Appelbaum; Reginald Clift; Jerald P Radich; Claudio Anasetti; C Dean Buckner
Bone marrow transplantation for chronic myelogenous leukemia.
Seminars in oncology 1995;22(4):405-11.
1995: Taner Demirer; F B Petersen; Frederick R Appelbaum; T A Barnett; Jean Sanders; H Joachim Deeg; Rainer Storb; Kristine C Doney; William I Bensinger; Kathleen Shannon Dorcy
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
1995: John T Slattery; Jean E Sanders; C Dean Buckner; R L Schaffer; K W Lambert; F P Langer; Claudio Anasetti; William I Bensinger; Lloyd Fisher; Frederick R Appelbaum
Graft-rejection and toxicity following bone marrow transplantation in relation to busulfan pharmacokinetics.
Bone marrow transplantation 1995;16(1):31-42.
1995: Frederick R Appelbaum
Allogeneic marrow transplantation and the use of hematopoietic growth factors.
Stem cells (Dayton, Ohio) 1995;13(4):344-50.
1995: Taner Demirer; Scott D Rowley; C Dean Buckner; Frederick R Appelbaum; Kathy Lilleby; Rainer Storb; K Schiffman; William I Bensinger
Peripheral-blood stem-cell collections after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(7):1714-9.
1995: Richard A Nash; Ruth Etzioni; Rainer Storb; T Furlong; T Gooley; Claudio Anasetti; Frederick R Appelbaum; Kristine C Doney; P Martin; J Slattery
Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study.
Blood 1995;85(12):3746-53.
1995: Taner Demirer; C Dean Buckner; Frederick R Appelbaum; F B Petersen; Scott D Rowley; Charles H Weaver; Kathy Lilleby; Jean Sanders; Thomas R Chauncey; Rainer Storb
Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Bone marrow transplantation 1995;15(6):915-22.
1995: Taner Demirer; T Gooley; C Dean Buckner; F B Petersen; Kathy Lilleby; Scott D Rowley; Jean Sanders; Rainer Storb; Frederick R Appelbaum; William I Bensinger
Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation.
Bone marrow transplantation 1995;15(6):907-13.
1995: Richard A Nash; K Seidel; Rainer Storb; Sherrill J Slichter; Friedrich Schuening; Frederick R Appelbaum; A B Becker; L Bolles; H Joachim Deeg; T Graham
Effects of rhIL-11 on normal dogs and after sublethal radiation.
Experimental hematology 1995;23(5):389-96.
1995: William I Bensinger; Charles H Weaver; Frederick R Appelbaum; Scott D Rowley; Taner Demirer; Jean Sanders; Rainer Storb; C Dean Buckner
Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.
Blood 1995;85(6):1655-8.
1995: H Joachim Deeg; K Seidel; Barbara Bruemmer; Margaret Sullivan Pepe; Frederick R Appelbaum
Impact of patient weight on non-relapse mortality after marrow transplantation.
Bone marrow transplantation 1995;15(3):461-8.
1995: Dana C Matthews; Frederick R Appelbaum; Janet F Eary; D R Fisher; Lawrence D Durack; S A Bush; T E Hui; Paul J Martin; D Mitchell; Oliver W Press
Development of a marrow transplant regimen for acute leukemia using targeted hematopoietic irradiation delivered by 131I-labeled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation.
Blood 1995;85(4):1122-31.
1995: I Langenmayer; C Weaver; C Dean Buckner; Kathy Lilleby; Frederick R Appelbaum; K Longin; Scott D Rowley; Rainer Storb; J Singer; William I Bensinger
Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
Bone marrow transplantation 1995;15(2):241-6.
1995: M H Lynch; F B Petersen; Frederick R Appelbaum; William I Bensinger; Reginald Clift; Rainer Storb; Jean E Sanders; John A Hansen; C Dean Buckner
Phase II study of busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for allogeneic bone marrow transplantation in patients with advanced myeloid malignancies.
Bone marrow transplantation 1995;15(1):59-64.
1995: Oliver W Press; Janet F Eary; Frederick R Appelbaum; Irwin D Bernstein
Myeloablative radiolabeled antibody therapy with autologous bone marrow transplantation for relapsed B cell lymphomas.
Cancer treatment and research 1995;76():281-97.
1995: Robert G Andrews; Robert Briddell; G H Knitter; Scott D Rowley; Frederick R Appelbaum; Ian K McNiece
Rapid engraftment by peripheral blood progenitor cells mobilized by recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in nonhuman primates.
Blood 1995;85(1):15-20.
1994: Charles H Weaver; F B Petersen; Frederick R Appelbaum; William I Bensinger; Oliver W Press; P Martin; Brenda M Sandmaier; H Joachim Deeg; John A Hansen; M Brunvand
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2559-66.
1994: D H Boldt; Kenneth J Kopecky; D Head; G Gehly; Jerald P Radich; Frederick R Appelbaum
Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.
Leukemia 1994;8(12):2118-26.
1994: Charles H Weaver; Reginald Clift; H Joachim Deeg; Rainer Storb; Frederick R Appelbaum; William I Bensinger; Kristine C Doney; John A Hansen; P O Martin; Jean Sanders
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
1994: Rainer Storb; R F Raff; Frederick R Appelbaum; H Joachim Deeg; T C Graham; Friedrich Schuening; Howard M Shulman; Cong Yu; Eileen Bryant; R Burnett
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
Blood 1994;84(10):3558-66.
1994: Charles H Weaver; William I Bensinger; Frederick R Appelbaum; Kathy Lilleby; Brenda M Sandmaier; M Brunvand; Scott D Rowley; S Petersdorf; Saul E Rivkin; T Gooley
Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
Bone marrow transplantation 1994;14(5):813-9.
1994: Jerald P Radich; Kenneth J Kopecky; D H Boldt; D Head; M L Slovak; R Babu; J Kirk; A Lee; P Kessler; Frederick R Appelbaum
Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction.
Leukemia 1994;8(10):1688-95.
1994: John Nemunaitis; M Ross; Barry Meisenberg; R O'Reilly; Kathy Lilleby; C Dean Buckner; Frederick R Appelbaum; W Buhles; J Singer; W P Peters
Phase I study of recombinant human interleukin-1 beta (rhIL-1 beta) in patients with bone marrow failure.
Bone marrow transplantation 1994;14(4):583-8.
1994: Claudio Anasetti; John A Hansen; Thomas Waldmann; Frederick R Appelbaum; J Davis; H Joachim Deeg; Kristine C Doney; Paul J Martin; R Nash; Rainer Storb
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Rainer Storb; Ruth Etzioni; Claudio Anasetti; Frederick R Appelbaum; C Dean Buckner; William I Bensinger; Eileen Bryant; Reginald Clift; H Joachim Deeg; Kristine C Doney
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: William I Bensinger; K Longin; Frederick R Appelbaum; Scott D Rowley; C Weaver; Kathy Lilleby; T Gooley; M Lynch; T Higano; J Klarnet
Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation.
British journal of haematology 1994;87(4):825-31.
1994: Robert G Andrews; Robert Briddell; G H Knitter; T Opie; M Bronsden; David Myerson; Frederick R Appelbaum; Ian K McNiece
In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons enhanced circulation of progenitor cells.
Blood 1994;84(3):800-10.
1994: Taner Demirer; C Dean Buckner; Kathy Lilleby; C Weaver; K Longin; Frederick R Appelbaum; William I Bensinger
Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease.
Cancer 1994;74(2):715-21.
1994: Janet F Eary; K R Pollard; Lawrence D Durack; A N Bice; Thomas K Lewellen; D Matthews; Oliver W Press; W B Nelp; Frederick R Appelbaum; Irwin D Bernstein
Post therapy imaging in high dose I-131 radioimmunotherapy patients.
Medical physics 1994;21(7):1157-62.
1994: A A Scott; D R Head; Kenneth J Kopecky; Frederick R Appelbaum; K S Theil; Michael R Grever; I-Ming Chen; M H Whittaker; B B Griffith; Jonathan D Licht
HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3.
Blood 1994;84(1):244-55.
1994: John Nemunaitis; Frederick R Appelbaum; Kathy Lilleby; W C Buhles; C Rosenfeld; Zella R Zeigler; R K Shadduck; jack w singer; W Meyer; C Dean Buckner
Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia.
Blood 1994;83(12):3473-9.
1994: T de Revel; Frederick R Appelbaum; Rainer Storb; Friedrich Schuening; Richard Nash; Joachim Deeg; Ian K McNiece; R Andrews; T Graham
Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs.
Blood 1994;83(12):3795-9.
1994: Rainer Storb; R F Raff; Frederick R Appelbaum; H Joachim Deeg; T C Graham; Friedrich Schuening; George E Sale; Eileen Bryant; K Seidel
Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.
Blood 1994;83(11):3384-9.
1994: A Busca; Claudio Anasetti; G Anderson; Frederick R Appelbaum; C Dean Buckner; Kristine C Doney; Paul J Martin; Effie W Petersdorf; Jean E Sanders; John A Hansen
Unrelated donor or autologous marrow transplantation for treatment of acute leukemia.
Blood 1994;83(10):3077-84.
1994: J E Anderson; Frederick R Appelbaum
Hematopoietic effects and clinical uses of granulocyte-macrophage colony-stimulating factor and PIXY321.
Current opinion in hematology 1994;1(3):203-9.
1994: H Joachim Deeg; C Beckham; Ralf Huss; David Myerson; H Greinix; Frederick R Appelbaum; T Graham; Friedrich Schuening; Rainer Storb
Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Blood 1994;83(8):2352-9.
1994: Richard A Nash; Friedrich Schuening; K Seidel; Frederick R Appelbaum; T Boone; H Joachim Deeg; T C Graham; Robert C Hackman; M Sullivan-Pepe; Rainer Storb
Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1994;83(7):1963-70.
1994: Hans-Peter Kiem; B Darovsky; Christof von Kalle; S Goehle; D Stewart; T Graham; Robert C Hackman; Frederick R Appelbaum; H Joachim Deeg; A Dusty Miller
Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells.
Blood 1994;83(6):1467-73.
1994: I Schwarzinger; R F Raff; M Flowers; Dietger Niederwieser; T Graham; Howard M Shulman; Frederick R Appelbaum; Friedrich Schuening; Rainer Storb
Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
Bone marrow transplantation 1994;13(3):303-9.
1994: M A Bean; T Graham; Frederick R Appelbaum; H Joachim Deeg; Friedrich Schuening; G E Sale; Rainer Storb
Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
Transplantation 1994;57(3):423-6.
1994: Scott I Bearman; Motomi Mori; P G Beatty; W G Meyer; C Dean Buckner; F B Petersen; Jean E Sanders; Claudio Anasetti; P Martin; Frederick R Appelbaum
Comparison of morbidity and mortality after marrow transplantation from HLA-genotypically identical siblings and HLA-phenotypically identical unrelated donors.
Bone marrow transplantation 1994;13(1):31-5.
1994: Friedrich Schuening; John Nemunaitis; Frederick R Appelbaum; Rainer Storb
Hematopoietic growth factors after allogeneic marrow transplantation in animal studies and clinical trials.
Bone marrow transplantation 1994;14 Suppl 4():S74-7.
1993: J E Anderson; M R Litzow; Frederick R Appelbaum; Gary Schoch; Lloyd Fisher; C Dean Buckner; F B Petersen; SW Crawford; Oliver W Press; Jean E Sanders
Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin's disease: the 21-year Seattle experience.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(12):2342-50.
1993: Frederick R Appelbaum
The use of colony stimulating factors in marrow transplantation.
Cancer 1993;72(11 Suppl):3387-92.
1993: John Nemunaitis; Frederick R Appelbaum; jack w singer; Kathy Lilleby; Steven Neil Wolff; J P Greer; P Bierman; D Resta; M Campion; D Levitt
Phase I trial with recombinant human interleukin-3 in patients with lymphoma undergoing autologous bone marrow transplantation.
Blood 1993;82(11):3273-8.
1993: C Collins; Janet F Eary; G Donaldson; C Vernon; Nigel Bush; Stephen H Petersdorf; R B Livingston; E E Gordon; C R Chapman; Frederick R Appelbaum
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(11):1839-44.
1993: Oliver W Press; Janet F Eary; Frederick R Appelbaum; Paul J Martin; C C Badger; W B Nelp; S Glenn; G Butchko; D Fisher; B Porter
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support.
The New England journal of medicine 1993;329(17):1219-24.
1993: Reginald Clift; J A Bianco; Frederick R Appelbaum; C Dean Buckner; jack w singer; L Bakke; William I Bensinger; Raleigh A Bowden; George B McDonald; M Schubert
A randomized controlled trial of pentoxifylline for the prevention of regimen-related toxicities in patients undergoing allogeneic marrow transplantation.
Blood 1993;82(7):2025-30.
1993: Kristine C Doney; C Dean Buckner; Lloyd Fisher; F B Petersen; Jean Sanders; Frederick R Appelbaum; Claudio Anasetti; C Badger; William I Bensinger; H Joachim Deeg
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Rainer Storb; R F Raff; Frederick R Appelbaum; H Joachim Deeg; William E Fitzsimmons; T C Graham; M Pepe; M Pettinger; George E Sale; R van der Jagt
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
Transplantation 1993;56(4):800-7.
1993: Charles H Weaver; C Dean Buckner; K Longin; Frederick R Appelbaum; Scott D Rowley; Kathy Lilleby; J Miser; Rainer Storb; John A Hansen; William I Bensinger
Syngeneic transplantation with peripheral blood mononuclear cells collected after the administration of recombinant human granulocyte colony-stimulating factor.
Blood 1993;82(7):1981-4.
1993: John Nemunaitis; Kathleen Shannon Dorcy; Frederick R Appelbaum; J Meyers; A Owens; R Day; D Ando; C O'Neill; D Buckner; J Singer
Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor.
Blood 1993;82(5):1422-7.
1993: Kristine C Doney; Rainer Storb; Frederick R Appelbaum; C Dean Buckner; J Sanders; J Singer; John A Hansen
Recombinant granulocyte-macrophage colony stimulating factor followed by immunosuppressive therapy for aplastic anaemia.
British journal of haematology 1993;85(1):182-4.
1993: Frederick R Appelbaum
The influence of total dose, fractionation, dose rate, and distribution of total body irradiation on bone marrow transplantation.
Seminars in oncology 1993;20(4 Suppl 4):3-10; quiz 11.
1993: J E Anderson; Frederick R Appelbaum; Lloyd Fisher; Gary Schoch; Howard M Shulman; Claudio Anasetti; William I Bensinger; Eileen Bryant; C Dean Buckner; Kristine C Doney
Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome.
Blood 1993;82(2):677-81.
1993: Frederick R Appelbaum
Indications for bone marrow transplantation (BMT) in the treatment of acute myeloid leukemia (AML).
Leukemia 1993;7(7):1081.
1993: F B Petersen; M H Lynch; Reginald Clift; Frederick R Appelbaum; Jean E Sanders; William I Bensinger; M C Benyunes; Kristine C Doney; Alexander Fefer; P Martin
Autologous marrow transplantation for patients with acute myeloid leukemia in untreated first relapse or in second complete remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1353-60.
1993: Charles H Weaver; Frederick R Appelbaum; F B Petersen; Reginald Clift; J Singer; Oliver W Press; William I Bensinger; J Bianco; P Martin; Claudio Anasetti
High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(7):1329-35.
1993: Janet F Eary; C Collins; M Stabin; C Vernon; Stephen H Petersdorf; M Baker; S Hartnett; S Ferency; S J Addison; Frederick R Appelbaum
Samarium-153-EDTMP biodistribution and dosimetry estimation.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(7):1031-6.
1993: R F Raff; E M Severns; Rainer Storb; T C Graham; George E Sale; Friedrich Schuening; Frederick R Appelbaum
Studies of the use of L-leucyl-L-leucine methyl ester in canine allogeneic marrow transplantation.
Transplantation 1993;55(6):1244-9.
1993: William I Bensinger; J Singer; Frederick R Appelbaum; Kathy Lilleby; K Longin; Scott D Rowley; E Clarke; Reginald Clift; J Hansen; T Shields
Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
Blood 1993;81(11):3158-63.
1993: Rainer Storb; R F Raff; T Graham; Frederick R Appelbaum; H J Deeg; Friedrich Schuening; Howard M Shulman; M Pepe
Marrow toxicity of fractionated vs. single dose total body irradiation is identical in a canine model.
International journal of radiation oncology, biology, physics 1993;26(2):275-83.
1993: William I Bensinger; T H Price; D C Dale; Frederick R Appelbaum; Reginald Clift; Kathy Lilleby; B Williams; Rainer Storb; ED Thomas; C Dean Buckner
The effects of daily recombinant human granulocyte colony-stimulating factor administration on normal granulocyte donors undergoing leukapheresis.
Blood 1993;81(7):1883-8.
1993: K Schiffman; Reginald Clift; Frederick R Appelbaum; Jean Sanders; William I Bensinger; F B Petersen; Scott D Rowley; R Hill; P Martin; Rainer Storb
Consequences of cryopreserving first remission autologous marrow for use after relapse in patients with acute myeloid leukemia.
Bone marrow transplantation 1993;11(3):227-32.
1993: R Pene; Frederick R Appelbaum; Lloyd Fisher; Kathy Lilleby; John Nemunaitis; Rainer Storb; C Dean Buckner
Use of granulocyte-macrophage colony-stimulating factor and erythropoietin in combination after autologous marrow transplantation.
Bone marrow transplantation 1993;11(3):219-22.
1993: R F Raff; Rainer Storb; T Graham; H Joachim Deeg; M Pepe; R Schaffer; G E Sale; Friedrich Schuening; Frederick R Appelbaum
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
Transplantation 1993;55(3):684-8.
1993: John Nemunaitis; C Anasetti; C Dean Buckner; Frederick R Appelbaum; Kathleen Shannon Dorcy; J Hansen; jack w singer
Long-term follow-up of 103 patients who received recombinant human granulocyte-macrophage colony-stimulating factor after unrelated donor bone marrow transplantation.
Blood 1993;81(3):865.
1993: Oliver W Press; Janet F Eary; C C Badger; Frederick R Appelbaum; G Wiseman; D Matthews; Paul J Martin; Irwin D Bernstein
High-dose radioimmunotherapy of lymphomas.
Cancer treatment and research 1993;68():13-22.
1993: Friedrich Schuening; Frederick R Appelbaum; H Joachim Deeg; M Sullivan-Pepe; T C Graham; Robert C Hackman; Krisztina Maria Zsebo; Rainer Storb
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1993;81(1):20-6.
1992: Robert G Andrews; William I Bensinger; G H Knitter; Stephen Bartelmez; K Longin; Irwin D Bernstein; Frederick R Appelbaum; Krisztina Maria Zsebo
The ligand for c-kit, stem cell factor, stimulates the circulation of cells that engraft lethally irradiated baboons.
Blood 1992;80(11):2715-20.
1992: R F Raff; Rainer Storb; T Graham; George E Sale; Howard M Shulman; M Pepe; H Joachim Deeg; Friedrich Schuening; Frederick R Appelbaum; J M Fidler
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Transplantation 1992;54(5):947-8.
1992: Claudio Anasetti; Paul J Martin; Rainer Storb; Frederick R Appelbaum; P G Beatty; J Davis; Kristine C Doney; H F Hill; P Stewart; K M Sullivan
Treatment of acute graft-versus-host disease with a nonmitogenic anti-CD3 monoclonal antibody.
Transplantation 1992;54(5):844-51.
1992: Frederick R Appelbaum; Dana C Matthews; Janet F Eary; C C Badger; M Kellogg; Oliver W Press; Paul J Martin; D R Fisher; W B Nelp; ED Thomas
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia.
Transplantation 1992;54(5):829-33.
1992: R F Raff; Rainer Storb; T Graham; J M Fidler; G E Sale; B Johnston; H Joachim Deeg; M Pepe; Friedrich Schuening; Frederick R Appelbaum
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
Transplantation 1992;54(5):813-20.
1992: Reginald Clift; C Dean Buckner; Frederick R Appelbaum; Gary Schoch; F B Petersen; William I Bensinger; Jean Sanders; K M Sullivan; Rainer Storb; J Singer
Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1723-9.
1992: Richard A Nash; Margaret Sullivan Pepe; Rainer Storb; Gary Longton; M Pettinger; Claudio Anasetti; Frederick R Appelbaum; Raleigh A Bowden; H Joachim Deeg; Kristine C Doney
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Frederick R Appelbaum; P A Brown; Brenda M Sandmaier; Rainer Storb; D R Fisher; H M Shulman; T C Graham; Friedrich Schuening; H Joachim Deeg; J A Bianco
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
Blood 1992;80(6):1608-13.
1992: William I Bensinger; C Dean Buckner; Reginald Clift; F B Petersen; J A Bianco; jack w singer; Frederick R Appelbaum; W Dalton; P Beatty; Alexander Fefer
Phase I study of busulfan and cyclophosphamide in preparation for allogeneic marrow transplant for patients with multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(9):1492-7.
1992: Robert G Andrews; Stephen Bartelmez; G H Knitter; David Myerson; Irwin D Bernstein; Frederick R Appelbaum; Krisztina Maria Zsebo
A c-kit ligand, recombinant human stem cell factor, mediates reversible expansion of multiple CD34+ colony-forming cell types in blood and marrow of baboons.
Blood 1992;80(4):920-7.
1992: F B Petersen; C Dean Buckner; Frederick R Appelbaum; Jean E Sanders; William I Bensinger; Rainer Storb; H Joachim Deeg; Robert P Witherspoon; K M Sullivan; Reginald Clift
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
1992: Kristine C Doney; M Pepe; Rainer Storb; Eileen Bryant; Claudio Anasetti; Frederick R Appelbaum; C Dean Buckner; Jean Sanders; J Singer; K Sullivan
Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone.
Blood 1992;79(10):2566-71.
1992: Dana C Matthews; C C Badger; D R Fisher; T E Hui; C Nourigat; Frederick R Appelbaum; Paul J Martin; Irwin D Bernstein
Selective radiation of hematolymphoid tissue delivered by anti-CD45 antibody.
Cancer research 1992;52(5):1228-34.
1992: M E Flowers; Kristine C Doney; Rainer Storb; H Joachim Deeg; Jean E Sanders; K M Sullivan; Eileen Bryant; Robert P Witherspoon; Frederick R Appelbaum; C Dean Buckner
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: F B Petersen; H J Deeg; C Dean Buckner; Frederick R Appelbaum; Rainer Storb; R A Clift; J E Sanders; William I Bensinger; R P Witherspoon; K M Sullivan
Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial.
International journal of radiation oncology, biology, physics 1992;23(5):1027-32.
1992: C Dean Buckner; Kristine C Doney; Jean Sanders; F Petersen; Frederick R Appelbaum
Marrow transplantation for patients with acute lymphoblastic leukemia: the Seattle experience.
Leukemia 1992;6 Suppl 2():193-5.
1992: Reginald Clift; C Dean Buckner; J Bianco; F Petersen; Frederick R Appelbaum
Marrow transplantation in patients with acute myeloid leukemia.
Leukemia 1992;6 Suppl 2():104-9.
1992: M Stockschlaeder; Rainer Storb; M Pepe; Gary Longton; G McDonald; Claudio Anasetti; Frederick R Appelbaum; Kristine C Doney; P Martin; K Sullivan
A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
British journal of haematology 1992;80(1):49-54.
1992: R H van der Jagt; C C Badger; Frederick R Appelbaum; Oliver W Press; Dana C Matthews; Janet F Eary; K A Krohn; Irwin D Bernstein
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model.
Cancer research 1992;52(1):89-94.
1992: Frederick R Appelbaum; C C Badger; Irwin D Bernstein; C Dean Buckner; H Joachim Deeg; Janet F Eary; Dana C Matthews; Oliver W Press; Rainer Storb; ED Thomas
Is there a better way to deliver total body irradiation?
Bone marrow transplantation 1992;10 Suppl 1():77-81.
1992: Rainer Storb; Gary Longton; Claudio Anasetti; Frederick R Appelbaum; P Beatty; William I Bensinger; S Crawford; H Joachim Deeg; Kristine C Doney; Alexander Fefer
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1992: K M Sullivan; Motomi Mori; Jean Sanders; MF Siadak; Robert P Witherspoon; Claudio Anasetti; Frederick R Appelbaum; William I Bensinger; R Bowden; C Dean Buckner
Late complications of allogeneic and autologous marrow transplantation.
Bone marrow transplantation 1992;10 Suppl 1():127-34.
1991: M A Bean; Rainer Storb; T Graham; R Raff; G E Sale; Friedrich Schuening; Frederick R Appelbaum
Prevention of transfusion-induced sensitization to minor histocompatibility antigens on DLA-identical canine marrow grafts by gamma irradiation of marrow donor blood.
Transplantation 1991;52(6):956-60.
1991: Friedrich Schuening; K Kawahara; A Dusty Miller; R To; S Goehle; D Stewart; K Mullally; Lloyd Fisher; T C Graham; Frederick R Appelbaum
Retrovirus-mediated gene transduction into long-term repopulating marrow cells of dogs.
Blood 1991;78(10):2568-76.
1991: C C Badger; J Davis; C Nourigat; Z M Wu; T E Hui; D R Fisher; Howard M Shulman; Frederick R Appelbaum; Janet F Eary; K A Krohn
Biodistribution and dosimetry following infusion of antibodies labeled with large amounts of 131I.
Cancer research 1991;51(21):5921-8.
1991: H T Greinix; Warren C Ladiges; T C Graham; S Maslan; R F Raff; Brenda M Sandmaier; Frederick R Appelbaum; Friedrich Schuening; H Joachim Deeg; Rainer Storb
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood 1991;78(8):2131-8.
1991: Robert G Andrews; G H Knitter; Stephen Bartelmez; K E Langley; D Farrar; R W Hendren; Frederick R Appelbaum; Irwin D Bernstein; K M Zsebo
Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates.
Blood 1991;78(8):1975-80.
1991: Frederick R Appelbaum
Radiolabeled monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.
Hematology/oncology clinics of North America 1991;5(5):1013-25.
1991: Dana C Matthews; Frederick R Appelbaum; Janet F Eary; T E Hui; D R Fisher; Paul J Martin; Lawrence D Durack; W B Nelp; Oliver W Press; C C Badger
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque.
Blood 1991;78(7):1864-74.
1991: R H Van der Jagt; Frederick R Appelbaum; F B Petersen; C L Bigelow; Lloyd Fisher; Gary Schoch; C Dean Buckner; Jean E Sanders; Rainer Storb; K M Sullivan
Busulfan and cyclophosphamide as a preparative regimen for bone marrow transplantation in patients with prior chest radiotherapy.
Bone marrow transplantation 1991;8(3):211-5.
1991: J A Bianco; Frederick R Appelbaum; John Nemunaitis; J Almgren; F Andrews; P Kettner; Anthony F Shields; J W Singer
Phase I-II trial of pentoxifylline for the prevention of transplant-related toxicities following bone marrow transplantation.
Blood 1991;78(5):1205-11.
1991: Richard A Nash; Friedrich Schuening; Frederick R Appelbaum; W P Hammond; T Boone; C F Morris; Sherrill J Slichter; Rainer Storb
Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor.
Blood 1991;78(4):930-7.
1991: K M Sullivan; E Agura; Claudio Anasetti; Frederick R Appelbaum; C Badger; S Bearman; K Erickson; M Flowers; J Hansen; T Loughran
Chronic graft-versus-host disease and other late complications of bone marrow transplantation.
Seminars in hematology 1991;28(3):250-9.
1991: Rainer Storb; Claudio Anasetti; Frederick R Appelbaum; William I Bensinger; C Dean Buckner; Reginald Clift; H Joachim Deeg; Kristine C Doney; J Hansen; T Loughran
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1991: C Dean Buckner; Reginald Clift; Frederick R Appelbaum; Rainer Storb; Alexander Fefer; F B Petersen; Jean E Sanders; K Sullivan; ED Thomas; John A Hansen
Effects of treatment regimens on post marrow transplant relapse.
Seminars in hematology 1991;28(3 Suppl 4):32-4.
1991: Kristine C Doney; Lloyd Fisher; Frederick R Appelbaum; C Dean Buckner; Rainer Storb; J Singer; Alexander Fefer; Claudio Anasetti; P Beatty; William I Bensinger
Treatment of adult acute lymphoblastic leukemia with allogeneic bone marrow transplantation. Multivariate analysis of factors affecting acute graft-versus-host disease, relapse, and relapse-free survival.
Bone marrow transplantation 1991;7(6):453-9.
1991: Claudio Anasetti; Paul J Martin; Rainer Storb; Frederick R Appelbaum; P G Beatty; E Calori; J Davis; Kristine C Doney; T Reichert; P Stewart
Prophylaxis of graft-versus-host disease by administration of the murine anti-IL-2 receptor antibody 2A3.
Bone marrow transplantation 1991;7(5):375-81.
1991: John Nemunaitis; C Dean Buckner; Frederick R Appelbaum; C S Higano; Motomi Mori; J Bianco; C Epstein; J Lipani; J Hansen; Rainer Storb
Phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation.
Blood 1991;77(9):2065-71.
1991: Paul J Martin; Gary Schoch; Lloyd Fisher; V Byers; Frederick R Appelbaum; George B McDonald; Rainer Storb; John A Hansen
A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.
Blood 1991;77(8):1821-8.
1991: Reginald Clift; C Dean Buckner; Frederick R Appelbaum; Eileen Bryant; Scott I Bearman; F B Petersen; Lloyd Fisher; Claudio Anasetti; P Beatty; William I Bensinger
Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens.
Blood 1991;77(8):1660-5.
1991: G C deGast; P G Beatty; D Amos; Eric Mickelson; K M Sullivan; J E Anderson; E R Giblett; Frederick R Appelbaum; Rainer Storb; H J Deeg
Transfusions shortly before HLA-matched marrow transplantation for leukemia are associated with a decrease in chronic graft-versus-host disease.
Bone marrow transplantation 1991;7(4):293-5.
1991: Oliver W Press; R Livingston; J Mortimer; C Collins; Frederick R Appelbaum
Treatment of relapsed non-Hodgkin's lymphomas with dexamethasone, high-dose cytarabine, and cisplatin before marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(3):423-31.
1991: Brenda M Sandmaier; Friedrich Schuening; J A Bianco; S J Rosenman; Irwin D Bernstein; S Goehle; Rainer Storb; Frederick R Appelbaum
Biochemical characterization of a unique canine myeloid antigen.
Leukemia 1991;5(2):125-30.
1991: Rainer Storb; M A Bean; Frederick R Appelbaum; Friedrich Schuening; T C Graham; R F Raff
Treatment of marrow donor blood products with gamma-irradiation prevents transfusion-induced sensitization to DLA-identical marrow grafts.
Transplantation proceedings 1991;23(1 Pt 2):1697-8.
1991: John Nemunaitis; J W Singer; C Dean Buckner; T Mori; J Laponi; R Hill; Rainer Storb; K M Sullivan; John A Hansen; Frederick R Appelbaum
Long-term follow-up of patients who received recombinant human granulocyte-macrophage colony stimulating factor after autologous bone marrow transplantation for lymphoid malignancy.
Bone marrow transplantation 1991;7(1):49-52.
1991: C Dean Buckner; Reginald Clift; Frederick R Appelbaum; Rainer Storb; F B Petersen; Jean E Sanders; ED Thomas; John A Hansen
Effects of treatment regimens in patients allografted for acute and chronic myelogenous leukemia.
Bone marrow transplantation 1991;7 Suppl 2():6-8.
1991: Oliver W Press; Janet F Eary; C C Badger; Paul J Martin; Frederick R Appelbaum; W B Nelp; Ronald Levy; R Miller; D Fisher; D Matthews
Radiolabeled antibody therapy of human B cell lymphomas.
Advances in experimental medicine and biology 1991;303():91-6.
1990: Reginald Clift; C Dean Buckner; Frederick R Appelbaum; Scott I Bearman; F B Petersen; Lloyd Fisher; Claudio Anasetti; P Beatty; William I Bensinger; Kristine C Doney
Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens.
Blood 1990;76(9):1867-71.
1990: T P Loughran; R F Raff; T C Graham; Frederick R Appelbaum; Friedrich Schuening; G E Sale; Rainer Storb
Transfusion of autologous cytotoxic cells leads to failure of unrelated, DLA-nonidentical marrow grafts.
Experimental hematology 1990;18(10):1126-31.
1990: Paul J Martin; Gary Schoch; Lloyd Fisher; V Byers; Claudio Anasetti; Frederick R Appelbaum; P G Beatty; Kristine C Doney; George B McDonald; Jean E Sanders
A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.
Blood 1990;76(8):1464-72.
1990: Rainer Storb; M Pepe; Claudio Anasetti; Frederick R Appelbaum; P Beatty; Kristine C Doney; P Martin; P Stewart; K M Sullivan; Robert P Witherspoon
What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?
Blood 1990;76(5):1037-45.
1990: Jerald P Radich; Kenneth J Kopecky; Cheryl L Willman; J Weick; D Head; Frederick R Appelbaum; Steven J Collins
N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance.
Blood 1990;76(4):801-7.
1990: Brenda M Sandmaier; Rainer Storb; Frederick R Appelbaum; W M Gallatin
An antibody that facilitates hematopoietic engraftment recognizes CD44.
Blood 1990;76(3):630-5.
1990: Friedrich Schuening; Rainer Storb; S Goehle; T C Graham; Robert C Hackman; Motomi Mori; L M Souza; Frederick R Appelbaum
Recombinant human granulocyte colony-stimulating factor accelerates hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Blood 1990;76(3):636-40.
1990: C Anasetti; P J Martin; J A Hansen; Frederick R Appelbaum; P G Beatty; K Doney; S Harkonen; A Jackson; T Reichert; P Stewart
A phase I-II study evaluating the murine anti-IL-2 receptor antibody 2A3 for treatment of acute graft-versus-host disease.
Transplantation 1990;50(1):49-54.
1990: Frederick R Appelbaum
Introduction and overview of interferon alfa in myeloproliferative and hemangiomatous diseases.
Seminars in hematology 1990;27(3 Suppl 4):1-5.
1990: John Nemunaitis; J W Singer; C Dean Buckner; D Durnam; C Epstein; R Hill; Rainer Storb; ED Thomas; Frederick R Appelbaum
Use of recombinant human granulocyte-macrophage colony-stimulating factor in graft failure after bone marrow transplantation.
Blood 1990;76(1):245-53.
1990: Rainer Storb; Frederick R Appelbaum; C Dean Buckner; Reginald Clift; Claudio Anasetti; P Beatty; J Bianco; Kristine C Doney; J Hansen; P Martin
HLA-identical marrow transplantation in the leukemias without T-cell depletion. The Seattle Marrow Transplant Team.
Bone marrow transplantation 1990;6 Suppl 1():80-4.
1990: Rainer Storb; Frederick R Appelbaum; John Nemunaitis; Friedrich Schuening; J Singer; C Epstein; C Dean Buckner; L M Souza; ED Thomas
Hematopoietic growth factors in marrow transplantation and radiation injury.
Bone marrow transplantation 1990;6 Suppl 1():116-20.
1990: K M Sullivan; Frederick R Appelbaum
Comparative trials of chemotherapy and bone marrow transplantation in acute nonlymphocytic leukemia.
[Rinshō ketsueki] The Japanese journal of clinical hematology 1990;31(5):527-33.
1990: Frederick R Appelbaum; J Barrall; Rainer Storb; Lloyd Fisher; Gary Schoch; R E Ramberg; Howard M Shulman; Claudio Anasetti; Scott I Bearman; P Beatty
Bone marrow transplantation for patients with myelodysplasia. Pretreatment variables and outcome.
Annals of internal medicine 1990;112(8):590-7.
1990: F B Petersen; Frederick R Appelbaum; R Hill; Lloyd Fisher; C L Bigelow; Jean E Sanders; K M Sullivan; William I Bensinger; Robert P Witherspoon; Rainer Storb
Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(4):638-47.
1990: J A Bianco; Frederick R Appelbaum
Biotherapy after marrow transplantation and the use of hematopoietic growth factors.
Current opinion in oncology 1990;2(2):289-96.
1990: S I Bearman; F B Petersen; R A Schor; J D Denney; Lloyd Fisher; Frederick R Appelbaum; C Dean Buckner
Radionuclide ejection fractions in the evaluation of patients being considered for bone marrow transplantation: risk for cardiac toxicity.
Bone marrow transplantation 1990;5(3):173-7.
1990: Warren C Ladiges; Rainer Storb; R F Raff; Frederick R Appelbaum; Brenda M Sandmaier; Friedrich Schuening; T Graham
Failure of anti-MHC antibodies to prevent GVHD in DLA mismatched unrelated canine marrow recipients.
Bone marrow transplantation 1990;5(1):43-6.
1990: Oliver W Press; Janet F Eary; C C Badger; Paul J Martin; Frederick R Appelbaum; W B Nelp; Kenneth A Krohn; D Fisher; B Porter; ED Thomas
High-dose radioimmunotherapy of B cell lymphomas.
Frontiers of radiation therapy and oncology 1990;24():204-13; discussion 225-7.
1990: Frederick R Appelbaum; John Nemunaitis; J W Singer; C Dean Buckner; Rainer Storb; ED Thomas
Use of recombinant human granulocyte macrophage colony-stimulating factor to speed engraftment and treat graft failure following marrow transplantation in man.
Haematology and blood transfusion 1990;33():736-40.
1990: Rainer Storb; C Dean Buckner; Reginald Clift; Frederick R Appelbaum; Kristine C Doney; P Martin; C Anasetti; J Hansen; J E Sanders; F B Petersen
Marrow grafting for acute leukemia: results and future treatment strategies.
Haematology and blood transfusion 1990;33():629-35.
1990: K M Sullivan; J Meyers; F B Petersen; R Bowden; G C Counts; M Banaji; M Schubert; J Clark; Reginald Clift; Frederick R Appelbaum
Supportive care of the marrow transplant recipient: the Seattle Experience.
Haematology and blood transfusion 1990;33():539-45.
1989: F B Petersen; C Dean Buckner; Frederick R Appelbaum; Reginald Clift; Jean E Sanders; William I Bensinger; Rainer Storb; Robert P Witherspoon; K M Sullivan; Scott I Bearman
Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1989;4(6):617-23.
1989: J A Bianco; Brenda M Sandmaier; P A Brown; C Badger; Irwin D Bernstein; Janet F Eary; Lawrence D Durack; Friedrich Schuening; Rainer Storb; Frederick R Appelbaum
Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.
Experimental hematology 1989;17(9):929-34.
1989: Frederick R Appelbaum
Marrow transplantation in the treatment of patients with lymphoma.
Current opinion in oncology 1989;1(1):47-54.
1989: F B Petersen; Frederick R Appelbaum; C L Bigelow; C Dean Buckner; R A Clift; Jean E Sanders; Rainer Storb; K M Sullivan; P L Weiden; A Fefer
High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma.
Bone marrow transplantation 1989;4(5):483-8.
1989: Scott I Bearman; Frederick R Appelbaum; A Back; F B Petersen; C Dean Buckner; K M Sullivan; H Gary Schoch; Lloyd Fisher; ED Thomas
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(9):1288-94.
1989: Friedrich Schuening; Rainer Storb; S Goehle; Richard Nash; T C Graham; Frederick R Appelbaum; Robert C Hackman; Brenda M Sandmaier; D L Urdal
Stimulation of canine hematopoiesis by recombinant human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1989;17(8):889-94.
1989: Friedrich Schuening; Rainer Storb; S Goehle; T C Graham; Frederick R Appelbaum; Robert C Hackman; L M Souza
Effect of recombinant human granulocyte colony-stimulating factor on hematopoiesis of normal dogs and on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1989;74(4):1308-13.
1989: Rainer Storb; R F Raff; Frederick R Appelbaum; T C Graham; Friedrich Schuening; George E Sale; M Pepe
Comparison of fractionated to single-dose total body irradiation in conditioning canine littermates for DLA-identical marrow grafts.
Blood 1989;74(3):1139-43.
1989: Rainer Storb; H Joachim Deeg; M Pepe; Kristine C Doney; Frederick R Appelbaum; P Beatty; William I Bensinger; C Dean Buckner; Reginald Clift; J Hansen
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Oliver W Press; Janet F Eary; C C Badger; Paul J Martin; Frederick R Appelbaum; Ronald Levy; R Miller; S Brown; W B Nelp; K A Krohn
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(8):1027-38.
1989: Frederick R Appelbaum; R F Raff; Rainer Storb; H Joachim Deeg; T C Graham; Brenda M Sandmaier; Friedrich Schuening
Use of trimetrexate for the prevention of graft-versus-host disease.
Bone marrow transplantation 1989;4(4):421-4.
1989: Frederick R Appelbaum
The clinical use of hematopoietic growth factors.
Seminars in hematology 1989;26(3 Suppl 3):7-14.
1989: Frederick R Appelbaum; P Brown; Brenda M Sandmaier; C Badger; Friedrich Schuening; T Graham; Rainer Storb
Antibody-radionuclide conjugates as part of a myeloablative preparative regimen for marrow transplantation.
Blood 1989;73(8):2202-8.
1989: Rainer Storb; H Joachim Deeg; M Pepe; Frederick R Appelbaum; Claudio Anasetti; P Beatty; William I Bensinger; R Berenson; C Dean Buckner; Reginald Clift
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1989: K M Sullivan; P L Weiden; Rainer Storb; Robert P Witherspoon; Alexander Fefer; Lloyd Fisher; C Dean Buckner; Claudio Anasetti; Frederick R Appelbaum; C Badger
Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia.
Blood 1989;73(6):1720-8.
1989: K M Sullivan; Rainer Storb; C Dean Buckner; Alexander Fefer; Lloyd Fisher; P L Weiden; Robert P Witherspoon; Frederick R Appelbaum; M Banaji; J Hansen
Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms.
The New England journal of medicine 1989;320(13):828-34.
1989: Martin S Tallman; Kenneth J Kopecky; D Amos; S Dahlberg; J S Hewlett; J C Files; C A Coltman; ED Thomas; Frederick R Appelbaum
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(3):326-37.
1989: Claudio Anasetti; D Amos; P G Beatty; Frederick R Appelbaum; William I Bensinger; C Dean Buckner; Reginald Clift; Kristine C Doney; Paul J Martin; Eric Mickelson
Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma.
The New England journal of medicine 1989;320(4):197-204.
1989: K M Sullivan; C Dean Buckner; Jean E Sanders; Claudio Anasetti; Frederick R Appelbaum; J Clark; Kristine C Doney; J Meyers; George E Sale; Rainer Storb
Long-term complications of bone marrow transplantation.
Progress in clinical and biological research 1989;309():367-74.
1989: C Dean Buckner; Jean Sanders; Frederick R Appelbaum
Allogeneic marrow transplantation for acute non-lymphoblastic leukemia: first remission versus after first relapse.
Bone marrow transplantation 1989;4 Suppl 1():244-6.
1989: R S Hill; P Mazza; D Amos; C Dean Buckner; Frederick R Appelbaum; P Martin; B J Still; S Sica; R Berenson; William I Bensinger
Engraftment in 86 with patients lymphoid malignancy after autologous marrow transplantation.
Bone marrow transplantation 1989;4(1):69-74.
1989: J Mortimer; M A Blinder; S Schulman; Frederick R Appelbaum; C Dean Buckner; R A Clift; J E Sanders; Rainer Storb; ED Thomas
Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(1):50-7.
1988: Paul J Martin; Reginald Clift; Lloyd Fisher; C Dean Buckner; John A Hansen; Frederick R Appelbaum; Kristine C Doney; K M Sullivan; Robert P Witherspoon; Rainer Storb
HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.
Blood 1988;72(6):1978-84.
1988: F B Petersen; Frederick R Appelbaum; C Dean Buckner; Jean E Sanders; Reginald Clift; R McGuffin; Scott I Bearman; N Flournoy; ED Thomas
Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy.
Bone marrow transplantation 1988;3(6):619-24.
1988: R F Raff; E Severns; Rainer Storb; P Martin; T Graham; Brenda M Sandmaier; Friedrich Schuening; George E Sale; Frederick R Appelbaum
L-leucyl-L-leucine methyl ester treatment of canine marrow and peripheral blood cells. Inhibition of proliferative responses with maintenance of the capacity for autologous marrow engraftment.
Transplantation 1988;46(5):655-60.
1988: Scott I Bearman; Frederick R Appelbaum; C Dean Buckner; F B Petersen; Lloyd Fisher; Reginald Clift; ED Thomas
Regimen-related toxicity in patients undergoing bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(10):1562-8.
1988: Rainer Storb; R F Raff; Frederick R Appelbaum; F W Schuening; Brenda M Sandmaier; T C Graham; ED Thomas
What radiation dose for DLA-identical canine marrow grafts?
Blood 1988;72(4):1300-4.
1988: Frederick R Appelbaum
Intensive chemotherapy or chemoradiotherapy with autologous marrow support as treatment for patients with solid tumors.
Hematology/oncology clinics of North America 1988;2(3):345-52.
1988: H Joachim Deeg; Rainer Storb; Gary Longton; T C Graham; H M Shulman; Frederick R Appelbaum; ED Thomas
Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity.
International journal of radiation oncology, biology, physics 1988;15(3):647-53.
1988: Frederick R Appelbaum; John Nemunaitis
Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) following autologous marrow transplantation in man.
Behring Institute Mitteilungen 1988;(83):145-8.
1988: Rainer Storb; R F Raff; Frederick R Appelbaum; F W Schuening; Brenda M Sandmaier; T C Graham
The influence of transfusions from unrelated DLA-matched or mismatched donors upon marrow grafts between DLA-identical canine littermates.
Transplantation 1988;46(2):334-6.
1988: John Nemunaitis; J W Singer; C Dean Buckner; R Hill; Rainer Storb; ED Thomas; Frederick R Appelbaum
Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.
Blood 1988;72(2):834-6.
1988: K M Sullivan; Robert P Witherspoon; Rainer Storb; H Joachim Deeg; S Dahlberg; Jean E Sanders; Frederick R Appelbaum; Kristine C Doney; P Weiden; Claudio Anasetti
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1988: K M Sullivan; Robert P Witherspoon; Rainer Storb; P Weiden; N Flournoy; S Dahlberg; H Joachim Deeg; Jean E Sanders; Kristine C Doney; Frederick R Appelbaum
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood 1988;72(2):546-54.
1988: Frederick R Appelbaum; Lloyd Fisher; ED Thomas
Chemotherapy v marrow transplantation for adults with acute nonlymphocytic leukemia: a five-year follow-up.
Blood 1988;72(1):179-84.
1988: Frederick R Appelbaum
Marrow transplantation for hematologic malignancies: a brief review of current status and future prospects.
Seminars in hematology 1988;25(3 Suppl 3):16-22.
1988: Warren C Ladiges; M Keast; Frederick R Appelbaum; Rainer Storb
Phenotypic characterization of canine lymphoma, using monoclonal antibodies and a microlymphocytotoxicity assay.
American journal of veterinary research 1988;49(6):870-2.
1988: Jean E Sanders; C Dean Buckner; D Amos; W Levy; Frederick R Appelbaum; Kristine C Doney; Rainer Storb; K M Sullivan; Robert P Witherspoon; ED Thomas
Ovarian function following marrow transplantation for aplastic anemia or leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(5):813-8.
1988: Frederick R Appelbaum
Reply to Z. Arlin "Bone marrow transplantation for chronic myelogenous leukemia: some thoughts about future prospects".
Leukemia 1988;2(4):251-2.
1988: Martin S Tallman; John Nemunaitis; Timothy R McGuire; G C Yee; T E Hughes; J D Almgren; Frederick R Appelbaum; C S Higano; R W McGuffin; J W Singer
Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
Transplantation 1988;45(4):810-3.
1988: S Riddell; Frederick R Appelbaum; C Dean Buckner; P Stewart; Reginald Clift; Jean Sanders; Rainer Storb; K Sullivan; ED Thomas
High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(4):576-82.
1988: H Joachim Deeg; J Aprile; Rainer Storb; T C Graham; Robert C Hackman; Frederick R Appelbaum; Friedrich Schuening
Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients.
Blood 1988;71(4):1138-40.
1988: Frederick R Appelbaum; T Graham; Brenda M Sandmaier; Friedrich Schuening; Rainer Storb
Sensitivity of newly transplanted marrow to further irradiation.
Transplantation 1988;45(4):813-4.
1988: Rainer Storb; H Joachim Deeg; Lloyd Fisher; Frederick R Appelbaum; C Dean Buckner; William I Bensinger; Reginald Clift; Kristine C Doney; C Irle; R McGuffin
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Rainer Storb; R F Raff; Frederick R Appelbaum; Friedrich Schuening; Brenda M Sandmaier; Howard M Shulman; H Joachim Deeg; T Graham
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
1988: Jean E Sanders; C Dean Buckner; K M Sullivan; Kristine C Doney; Frederick R Appelbaum; Robert P Witherspoon; R Storb; ED Thomas
Growth and development in children after bone marrow transplantation.
Hormone research 1988;30(2-3):92-7.
1988: Jean E Sanders; C Dean Buckner; Reginald Clift; Alexander Fefer; R McGuffin; Rainer Storb; Frederick R Appelbaum; William I Bensinger; P Beatty; Kristine C Doney
Second marrow transplants in patients with leukemia who relapse after allogeneic marrow transplantation.
Bone marrow transplantation 1988;3(1):11-9.
1987: Kristine C Doney; C Dean Buckner; Kenneth J Kopecky; Jean E Sanders; Frederick R Appelbaum; Reginald Clift; K Sullivan; Robert P Witherspoon; Rainer Storb; ED Thomas
Marrow transplantation for patients with acute lymphoblastic leukemia in first marrow remission.
Bone marrow transplantation 1987;2(4):355-63.
1987: Rainer Storb; H Joachim Deeg; Frederick R Appelbaum; F W Schuening; R F Raff; T C Graham
The biology of graft rejection in a canine model of marrow transplantation.
Transplantation proceedings 1987;19(6 Suppl 7):18-22.
1987: Frederick R Appelbaum; J Barrall; Rainer Storb; R Ramberg; Kristine C Doney; G E Sale; ED Thomas
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia.
Experimental hematology 1987;15(11):1134-9.
1987: J D Meyers; N Flournoy; Jean E Sanders; R W McGuffin; B A Newton; Lloyd Fisher; Lawrence George Lum; Frederick R Appelbaum; Kristine C Doney; K M Sullivan
Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation.
Annals of internal medicine 1987;107(6):809-16.
1987: G E Sale; Jukka Rajantie; K Doney; Frederick R Appelbaum; Rainer Storb; ED Thomas
Does histologic grading of inflammation in bone marrow predict the response of aplastic anaemia patients to antithymocyte globulin therapy?
British journal of haematology 1987;67(3):261-6.
1987: Friedrich Schuening; Rainer Storb; S Goehle; J Meyer; T C Graham; H Joachim Deeg; Frederick R Appelbaum; G E Sale; L Graf; T P Loughran
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Transplantation 1987;44(5):607-13.
1987: Reginald Clift; C Dean Buckner; ED Thomas; Kenneth J Kopecky; Frederick R Appelbaum; Martin S Tallman; Rainer Storb; Jean Sanders; K Sullivan; M Banaji
The treatment of acute non-lymphoblastic leukemia by allogeneic marrow transplantation.
Bone marrow transplantation 1987;2(3):243-58.
1987: Frederick R Appelbaum
Marrow transplantation for malignant lymphoma.
Bone marrow transplantation 1987;2(3):227-31.
1987: Martin S Tallman; Frederick R Appelbaum; D Amos; R S Goldberg; R B Livingston; J Mortimer; P L Weiden; ED Thomas
Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(6):918-26.
1987: Frederico Luiz Dulley; E J Kanfer; Frederick R Appelbaum; D Amos; R S Hill; C Dean Buckner; H M Shulman; George B McDonald; ED Thomas
Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation.
Transplantation 1987;43(6):870-3.
1987: E J Kanfer; C Dean Buckner; Alexander Fefer; Rainer Storb; Frederick R Appelbaum; R S Hill; D Amos; Kristine C Doney; Reginald Clift; H M Shulman
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
Bone marrow transplantation 1987;1(4):339-46.
1987: Kristine C Doney; Rainer Storb; C Dean Buckner; R McGuffin; R Witherspoon; H Joachim Deeg; Frederick R Appelbaum; K M Sullivan; ED Thomas
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: E J Kanfer; F B Petersen; C Dean Buckner; P Stewart; Rainer Storb; R S Hill; Frederick R Appelbaum; Reginald Clift; Kristine C Doney; H M Shulman
Phase I study of high-dose dimethylbusulfan followed by autologous bone marrow transplantation in patients with advanced malignancy.
Cancer treatment reports 1987;71(1):101-2.
1986: Rainer Storb; H J Kolb; H Joachim Deeg; P L Weiden; Frederick R Appelbaum; T C Graham; ED Thomas
Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
Bone marrow transplantation 1986;1(2):167-77.
1986: H Joachim Deeg; K M Sullivan; C Dean Buckner; Rainer Storb; Frederick R Appelbaum; Reginald Clift; Kristine C Doney; Jean E Sanders; Robert P Witherspoon; ED Thomas
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Jean E Sanders; S Pritchard; P Mahoney; D Amos; C Dean Buckner; Robert P Witherspoon; H J Deeg; Kristine C Doney; K M Sullivan; Frederick R Appelbaum
Growth and development following marrow transplantation for leukemia.
Blood 1986;68(5):1129-35.
1986: R S Hill; F B Petersen; Rainer Storb; Frederick R Appelbaum; Kristine C Doney; S Dahlberg; R Ramberg; ED Thomas
Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease.
Blood 1986;67(3):811-6.
1986: H Joachim Deeg; J Aprile; T C Graham; Frederick R Appelbaum; Rainer Storb
Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.
Blood 1986;67(2):537-9.
1985: N R Jin; R S Hill; F B Petersen; C Dean Buckner; P S Stewart; D Amos; Frederick R Appelbaum; R A Clift; W I Bensinger; J E Sanders
Marrow harvesting for autologous marrow transplantation.
Experimental hematology 1985;13(9):879-84.
1985: Rainer Storb; H Joachim Deeg; ED Thomas; Frederick R Appelbaum; C Dean Buckner; M A Cheever; Reginald Clift; Kristine C Doney; N Flournoy; M S Kennedy
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: P Stewart; C Dean Buckner; William I Bensinger; Frederick R Appelbaum; A Fefer; Reginald Clift; Rainer Storb; J Sanders; J Meyers; R Hill
Autologous marrow transplantation in patients with acute nonlymphocytic leukemia in first remission.
Experimental hematology 1985;13(4):267-72.